HSD17B10

UniProt ID: Q99714
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

HSD17B10 (also known as HADH2, SCHAD, SDR5C1, MRPP2, and historically ERAB/ABAD) is a mitochondrial-matrix protein of the short-chain dehydrogenase/reductase (SDR) family that acts as a functional homotetramer and is a genuinely moonlighting, multifunctional enzyme. In its catalytic role it is an NAD+-dependent dehydrogenase whose physiologically important activity is (S)-2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) in L-isoleucine catabolism, oxidizing (2S,3S)-3-hydroxy-2-methylbutanoyl-CoA to 2-methyl-3-oxobutanoyl-CoA. It has broad (S)-3-hydroxyacyl-CoA dehydrogenase activity on short/medium straight-chain acyl-CoAs and weaker intrinsic 17-beta-/3-alpha-hydroxysteroid and alcohol dehydrogenase activities toward steroid hormones (including the neurosteroid allopregnanolone/brexanolone), bile acids and other substrates. Independently of its enzymatic activity, it moonlights as MRPP2, an essential non-catalytic subunit of mitochondrial RNase P (together with the methyltransferase TRMT10C/MRPP1 and the nuclease PRORP/MRPP3), which performs 5'-end processing of mitochondrial tRNAs; the TRMT10C-HSD17B10 subcomplex additionally catalyzes N1-methylation of purine-9 (m1A9/m1G9) of mt-tRNAs and acts as a tRNA-maturation platform that supports downstream 3'-processing by ELAC2 and 3'-CCA addition by TRNT1. It localizes to the mitochondrial matrix and associates with the mitochondrial nucleoid. Loss-of-function mutations in the X-linked HSD17B10 gene cause HSD10 mitochondrial disease (a progressive infantile/childhood neurodegeneration with cardiomyopathy), and disease severity tracks with the RNase P/tRNA-processing and mitochondrial-integrity defect rather than with residual dehydrogenase activity.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0004303 estradiol 17-beta-dehydrogenase [NAD(P)+] activity
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetically inferred 17-beta-estradiol dehydrogenase activity. This is a real but weak intrinsic in-vitro activity of HSD17B10 (its k_cat for 17-beta-oestradiol is orders of magnitude below the 3-hydroxyacyl-CoA activity), not its physiological core function. Kept as a valid but non-core side activity.
Reason: Confirmed intrinsic activity but of low catalytic efficiency and not the evolved core function; the steroid activities are minor relative to 3-hydroxyacyl-CoA/MHBD chemistry.
Supporting Evidence:
PMID:10600649
The k(cat) of the ADH activity was three orders of magnitude less than the l-3-hydroxyacyl-CoA dehydrogenase activity but was comparable with that of the enzyme's hydroxysteroid dehydrogenase (HSD) activity for oxidizing 17beta-oestradiol
GO:0005739 mitochondrion
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic inference of mitochondrial localization, consistent with all experimental data placing HSD17B10 in the mitochondrion (matrix/nucleoid).
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
SUBCELLULAR LOCATION: Mitochondrion
GO:0006631 fatty acid metabolic process
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Broad fatty-acid metabolic process, phylogenetically inferred. HSD17B10 does act as a (S)-3-hydroxyacyl-CoA dehydrogenase, but the more specific and better supported process annotations are fatty acid beta-oxidation and isoleucine catabolism. Kept as a correct but general, non-core parent.
Reason: Correct but too general; more specific child processes (beta-oxidation, isoleucine catabolism) are separately annotated.
GO:0008209 androgen metabolic process
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Androgen metabolic process inferred phylogenetically. Reflects the weak in-vitro testosterone/androstanediol dehydrogenase side activities; not a demonstrated physiological role. Kept as non-core.
Reason: Minor in-vitro steroid side activity, not the evolved core function.
GO:0008210 estrogen metabolic process
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Estrogen metabolic process inferred phylogenetically; reflects weak in-vitro 17-beta-estradiol dehydrogenase side activity. Kept as non-core.
Reason: Minor in-vitro steroid side activity, not the evolved core function.
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic (Rhea/EC 1.1.1.35) assignment of (3S)-3-hydroxyacyl-CoA dehydrogenase activity. This is a genuine, well-established core catalytic activity of HSD17B10, independently supported by multiple experimental annotations below. Accept.
Supporting Evidence:
PMID:9553139
This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the D-isomers.
GO:0004022 alcohol dehydrogenase (NAD+) activity
IEA
GO_REF:0000116
MARK AS OVER ANNOTATED
Summary: Generic alcohol dehydrogenase (NAD+) activity assigned electronically from Rhea corticosteroid/steroid reactions. HSD17B10 does have a very weak intrinsic alcohol dehydrogenase activity (e.g. on 2-propanol), but this broad term is an over-annotation of what is really a hydroxysteroid/hydroxyacyl-CoA dehydrogenase; the generic parent is uninformative for this gene.
Reason: Over-broad electronic term; the real chemistry is hydroxysteroid/hydroxyacyl-CoA dehydrogenation and the generic ADH activity is trivial and misleading.
Supporting Evidence:
PMID:10600649
The k(cat) of the ADH activity was three orders of magnitude less than the l-3-hydroxyacyl-CoA dehydrogenase activity
GO:0004303 estradiol 17-beta-dehydrogenase [NAD(P)+] activity
IEA
GO_REF:0000120
KEEP AS NON CORE
Summary: Electronic (Rhea/EC 1.1.1.62) assignment of 17-beta-estradiol dehydrogenase activity. Real but weak intrinsic side activity; kept as non-core (see the corresponding experimental annotations).
Reason: Minor in-vitro steroid side activity, not the evolved core function.
GO:0005739 mitochondrion
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic mitochondrial localization, consistent with all experimental data.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
SUBCELLULAR LOCATION: Mitochondrion
GO:0008709 cholate 7-alpha-dehydrogenase (NAD+) activity
IEA
GO_REF:0000120
KEEP AS NON CORE
Summary: Electronic (Rhea/EC 1.1.1.159) assignment of cholate 7-alpha-dehydrogenase activity, matching the in-vitro bile-acid activity characterized for the human enzyme. Real but non-core (in-vitro bile-acid metabolism).
Reason: In-vitro bile-acid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid (5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid
GO:0016509 long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
IEA
GO_REF:0000116
MARK AS OVER ANNOTATED
Summary: Electronic (Rhea:31159, hydroxyhexadecanoyl-CoA) assignment of LONG-chain 3-hydroxyacyl-CoA dehydrogenase activity. HSD17B10 actually PREFERS short- and medium-chain substrates and is a poor long-chain enzyme; this specific long-chain child term over-states its chain-length specificity.
Reason: HSD17B10 preferentially accepts straight medium- and short-chain acyl-CoA; the long-chain-specific term misrepresents its substrate preference.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Preferentially accepts straight medium- and short-chain acyl-CoA substrates
GO:0042645 mitochondrial nucleoid
IEA
GO_REF:0000044
ACCEPT
Summary: Electronic (UniProt SubCell) mitochondrial-nucleoid localization, supported experimentally: HSD17B10 (as part of the RNase P machinery) associates with mtDNA nucleoids to initiate RNA processing.
Supporting Evidence:
PMID:24703694
mitochondrial RNA processing enzymes involved in tRNA excision, ribonuclease P (RNase P) and ELAC2, as well as a subset of nascent mitochondrial ribosomal proteins (MRPs) associate with nucleoids to initiate RNA processing and ribosome assembly
GO:0044594 17-beta-hydroxysteroid dehydrogenase (NAD+) activity
IEA
GO_REF:0000116
KEEP AS NON CORE
Summary: Electronic (Rhea:41992) assignment of 17-beta-hydroxysteroid dehydrogenase activity; corresponds to the enzyme's name-giving but catalytically weak steroid side activity. Kept as non-core.
Reason: Minor in-vitro steroid side activity, not the evolved core function.
GO:0047015 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic (Rhea:13281/EC 1.1.1.178) assignment of 2-methyl-3-hydroxybutyryl-CoA (MHBD) dehydrogenase activity. This is the physiologically most important catalytic activity of HSD17B10 (isoleucine catabolism) and is strongly supported experimentally. Accept as a core molecular function.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Reaction=(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA + NAD(+) = 2-methyl-3-
GO:0047035 testosterone dehydrogenase (NAD+) activity
IEA
GO_REF:0000120
KEEP AS NON CORE
Summary: Electronic (Rhea:14929/EC 1.1.1.239) assignment of testosterone dehydrogenase activity; a demonstrated in-vitro steroid side activity (see IDA below). Kept as non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
GO:0047044 androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity
IEA
GO_REF:0000120
KEEP AS NON CORE
Summary: Electronic (Rhea:42004/EC 1.1.1.53) assignment of androstanediol dehydrogenase activity, matching the in-vitro 3-alpha-hydroxysteroid activity. Non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
GO:0106281 chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity
IEA
GO_REF:0000116
KEEP AS NON CORE
Summary: Electronic (Rhea:42036) bile-acid 7-alpha-dehydrogenase activity, also supported by IDA (PMID:12917011). Real but non-core in-vitro bile-acid activity.
Reason: In-vitro bile-acid side activity, not the evolved core function.
GO:0106282 isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
IEA
GO_REF:0000116
KEEP AS NON CORE
Summary: Electronic (Rhea:42024) bile-acid 7-beta-dehydrogenase activity, supported by IDA (PMID:12917011). Non-core in-vitro bile-acid activity.
Reason: In-vitro bile-acid side activity, not the evolved core function.
GO:0106283 ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
IEA
GO_REF:0000116
KEEP AS NON CORE
Summary: Electronic (Rhea:42028) bile-acid 7-beta-dehydrogenase activity, supported by IDA (PMID:12917011). Non-core in-vitro bile-acid activity.
Reason: In-vitro bile-acid side activity, not the evolved core function.
GO:0005515 protein binding
IPI
PMID:18984158
RNase P without RNA: identification and functional reconstit...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding to TRMT10C (Q7L0Y3), from the study that identified HSD17B10/MRPP2 as a mitochondrial RNase P subunit. The interaction is real and biologically central (MRPP1-MRPP2 subcomplex), but the bare "protein binding" term is uninformative; the functional consequence is captured by the RNase P complex / tRNA-processing annotations.
Reason: Uninformative generic protein-binding term; the meaningful TRMT10C interaction is captured by the mitochondrial RNase P complex and tRNA-processing annotations.
Supporting Evidence:
PMID:18984158
composed of a tRNA methyltransferase, a short-chain dehydrogenase/reductase- family member, and a protein of hitherto unknown functional and evolutionary origin
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding to TRMT10C (Q7L0Y3) from a large-scale interactome study. Bare "protein binding" is uninformative; functional meaning captured elsewhere.
Reason: Uninformative generic protein-binding term.
GO:0005515 protein binding
IPI
PMID:29128334
A Map of Human Mitochondrial Protein Interactions Linked to ...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding to EEF2 (P13639) from a mitochondrial neurodegeneration interactome map. Bare "protein binding" is uninformative and this interaction has no established functional role for HSD17B10.
Reason: Uninformative generic protein-binding term; interaction of unclear significance.
GO:0005515 protein binding
IPI
PMID:29128334
A Map of Human Mitochondrial Protein Interactions Linked to ...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding to TRAP1 (Q12931) from a mitochondrial interactome map. Bare "protein binding" is uninformative; no established functional role.
Reason: Uninformative generic protein-binding term; interaction of unclear significance.
GO:0005515 protein binding
IPI
PMID:29880640
Structural insight into the human mitochondrial tRNA purine ...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding to TRMT10C (Q7L0Y3) from the structural study of the MRPP1/MRPP2 complex. Real and central, but bare "protein binding" is uninformative; captured by the RNase P/methyltransferase complex annotations.
Reason: Uninformative generic protein-binding term; the TRMT10C interaction is captured by the complex/process annotations.
GO:0005515 protein binding
IPI
PMID:32814053
Interactome Mapping Provides a Network of Neurodegenerative ...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding to APP/amyloid-beta (P05067) from a neurodegenerative-disease interactome study. The Aβ interaction (ABAD/ERAB) is a real disease-association but is non-core; the bare term is uninformative.
Reason: Uninformative generic protein-binding term; Aβ interaction is a disease association, not a core function.
GO:0005515 protein binding
IPI
PMID:32825572
Study of Biomolecular Interactions of Mitochondrial Proteins...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding to APP/amyloid-beta processed peptide (P05067-PRO_0000000092) from a study of Alzheimer-related mitochondrial protein interactions. Non-core disease association; bare term uninformative.
Reason: Uninformative generic protein-binding term; Aβ interaction is a disease association, not a core function.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding to TRMT10C (Q7L0Y3) from a proteome-scale interactome study. Bare "protein binding" uninformative; functional meaning captured elsewhere.
Reason: Uninformative generic protein-binding term.
GO:0005515 protein binding
IPI
PMID:9338779
An intracellular protein that binds amyloid-beta peptide and...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding to APP/amyloid-beta (P05067) from the original ERAB/Aβ discovery paper. Real disease-association interaction but non-core; the bare term is uninformative.
Reason: Uninformative generic protein-binding term; Aβ interaction is a disease association, not a core function.
GO:0006550 L-isoleucine catabolic process
IEA
GO_REF:0000041
ACCEPT
Summary: Electronic (UniPathway) assignment of L-isoleucine catabolism, the pathway in which HSD17B10's MHBD activity acts. Strongly supported experimentally (see IDA annotations). Core biological process.
Supporting Evidence:
PMID:20077426
the mitochondrial enzyme 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) involved in isoleucine metabolism
GO:0006635 fatty acid beta-oxidation
IEA
GO_REF:0000041
ACCEPT
Summary: Electronic (UniPathway) assignment of fatty acid beta-oxidation, where HSD17B10 acts as a short/medium-chain (S)-3-hydroxyacyl-CoA dehydrogenase (third step of the cycle). Supported by IDA (PMID:12917011). Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid
GO:0006699 bile acid biosynthetic process
IEA
GO_REF:0000041
KEEP AS NON CORE
Summary: Electronic (UniPathway) assignment of bile-acid metabolism, reflecting the in-vitro bile-acid (7-alpha/7-beta-hydroxy) dehydrogenase activities. A real but in-vitro, non-core role. Kept as non-core.
Reason: Based on in-vitro bile-acid dehydrogenase activities; physiological contribution to bile-acid biosynthesis is not established.
GO:0160241 cardiolipin dehydrogenase (NAD+) activity
IDA
PMID:26338420
Myxococcus CsgA, Drosophila Sniffer, and human HSD10 are car...
KEEP AS NON CORE
Summary: IDA for a phospholipase C-like / cardiolipin-oxidizing activity, with a preference for cardiolipin bearing oxidized fatty acids, proposed to protect against reactive oxygen species. Experimentally supported in vitro but a distinct, non-core moonlighting activity. Keep as non-core.
Reason: Experimentally supported in-vitro activity but a separate moonlighting role, not the evolved core (isoleucine/tRNA) functions.
Supporting Evidence:
PMID:26338420
HSD10 exhibits a strong preference for cardiolipin with oxidized fatty acids.
GO:0047035 testosterone dehydrogenase (NAD+) activity
IDA
PMID:28888424
Novel patient missense mutations in the HSD17B10 gene affect...
KEEP AS NON CORE
Summary: IDA testosterone dehydrogenase activity from biochemical characterization of the recombinant enzyme. A demonstrated in-vitro steroid side activity; kept as non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
GO:0001680 tRNA 3'-terminal CCA addition
IDA
PMID:38824131
Structural basis for human mitochondrial tRNA maturation.
KEEP AS NON CORE
Summary: IDA (ComplexPortal) involvement in 3'-CCA addition: cryo-EM shows the TRMT10C/SDR5C1 maturation platform retains the tRNA and presents it to the CCA-adding enzyme TRNT1. HSD17B10 participates as part of the platform rather than catalyzing CCA addition itself. Accept as a valid (non-core) process role.
Reason: Real platform role in CCA addition, but ancillary to the core 5'-processing/ RNase P function; HSD17B10 does not itself add CCA.
Supporting Evidence:
PMID:29040705
presents the nascent tRNA to the mitochondrial CCA-adding enzyme
GO:0005739 mitochondrion
NAS
PMID:21593607
Involvement of human ELAC2 gene product in 3' end processing...
ACCEPT
Summary: NAS mitochondrial localization; consistent with all experimental evidence.
GO:0042780 tRNA 3'-end processing
IDA
PMID:39516281
Structural basis of 3'-tRNA maturation by the human mitochon...
KEEP AS NON CORE
Summary: IDA (ComplexPortal) involvement in tRNA 3'-end processing: cryo-EM of the mitochondrial RNase Z complex (ELAC2/SDR5C1/TRMT10C) shows the SDR5C1/TRMT10C platform supports ELAC2-catalyzed 3'-processing. A real, platform-associated role; kept as non-core relative to the 5'-processing core.
Reason: Platform-supported 3'-processing role; ancillary to the core RNase P 5'-processing function.
Supporting Evidence:
PMID:29040705
significantly enhances the efficiency of ELAC2-catalyzed 3'-processing for 17 of the 22 tRNAs
GO:1902494 catalytic complex
IPI
PMID:38824131
Structural basis for human mitochondrial tRNA maturation.
KEEP AS NON CORE
Summary: Part_of a catalytic complex (ComplexPortal), a generic parent of the mitochondrial RNase P / tRNA-maturation complexes HSD17B10 belongs to. Correct but very general; more specific complex terms (mitochondrial ribonuclease P complex, endoribonuclease complex) are separately annotated.
Reason: Correct but over-general complex term; superseded by specific mitochondrial RNase P complex annotations.
GO:1902555 endoribonuclease complex
IDA
PMID:39516281
Structural basis of 3'-tRNA maturation by the human mitochon...
KEEP AS NON CORE
Summary: IDA part_of an endoribonuclease complex (the mitochondrial RNase Z / ELAC2-SDR5C1-TRMT10C complex from cryo-EM). Correct but general; the specific mitochondrial RNase P complex term is the core CC.
Reason: Correct but general complex term; the specific mitochondrial RNase P complex is the core cellular component.
Supporting Evidence:
PMID:39516281
cryo-EM structures of the mitochondrial RNase Z complex (ELAC2/SDR5C1/TRMT10C)
GO:0005739 mitochondrion
IDA
PMID:29880640
Structural insight into the human mitochondrial tRNA purine ...
ACCEPT
Summary: IDA mitochondrial localization from the RNase P structural study. Accept.
GO:0030678 mitochondrial ribonuclease P complex
IPI
PMID:29880640
Structural insight into the human mitochondrial tRNA purine ...
ACCEPT
Summary: Part_of the mitochondrial RNase P complex, from structural characterization of the MRPP1/MRPP2 (and RNase P) complexes. This is a core cellular component for HSD17B10/MRPP2. Accept.
Supporting Evidence:
PMID:29040705
The human mitochondrial RNase P is composed of three protein subunits: mitochondrial RNase P proteins 1, 2 and 3 (MRPP1, MRPP2 and MRPP3, respectively)
GO:0097745 mitochondrial tRNA 5'-end processing
IDA
PMID:29880640
Structural insight into the human mitochondrial tRNA purine ...
ACCEPT
Summary: IDA involvement in mitochondrial tRNA 5'-end processing, the core RNase P function of HSD17B10/MRPP2. Accept as a core biological process.
Supporting Evidence:
PMID:18984158
extra nucleotides at their 5' ends are removed by an endonuclease called RNase P
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
EXP
PMID:10600649
Intrinsic alcohol dehydrogenase and hydroxysteroid dehydroge...
ACCEPT
Summary: EXP (3S)-3-hydroxyacyl-CoA dehydrogenase activity, kinetically characterized on the purified enzyme. Core catalytic activity. Accept.
Supporting Evidence:
PMID:10600649
The k(cat) of the ADH activity was three orders of magnitude less than the l-3-hydroxyacyl-CoA dehydrogenase activity
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
EXP
PMID:26950678
A novel HSD17B10 mutation impairing the activities of the mi...
ACCEPT
Summary: EXP 3-hydroxyacyl-CoA dehydrogenase activity, assayed together with RNase P activities for the K212E disease mutant. Core catalytic activity. Accept.
Supporting Evidence:
PMID:26950678
the p.K212E mutation impairs the SDR5C1-dependent mitochondrial RNase P activities
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
EXP
PMID:9553139
A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is id...
ACCEPT
Summary: EXP 3-hydroxyacyl-CoA dehydrogenase activity from cloning/characterization of the purified human brain enzyme. Core catalytic activity. Accept.
Supporting Evidence:
PMID:9553139
This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the D-isomers.
GO:0004303 estradiol 17-beta-dehydrogenase [NAD(P)+] activity
EXP
PMID:10600649
Intrinsic alcohol dehydrogenase and hydroxysteroid dehydroge...
KEEP AS NON CORE
Summary: EXP 17-beta-estradiol dehydrogenase activity, kinetically characterized. Real but weak intrinsic steroid activity; kept as non-core.
Reason: Weak in-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:10600649
comparable with that of the enzyme's hydroxysteroid dehydrogenase (HSD) activity for oxidizing 17beta-oestradiol
GO:0004303 estradiol 17-beta-dehydrogenase [NAD(P)+] activity
EXP
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
KEEP AS NON CORE
Summary: EXP 17-beta-estradiol/hydroxysteroid dehydrogenase activity from the expanded substrate screen. Weak in-vitro steroid activity; non-core.
Reason: Weak in-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
3alpha-OH and 17beta-OH activities with sex steroids
GO:0005739 mitochondrion
EXP
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
ACCEPT
Summary: EXP mitochondrial localization by confocal/electron microscopy; the human enzyme carries an N-terminal mitochondrial targeting signal. Accept.
Supporting Evidence:
PMID:12917011
the human form is localized to mitochondria
GO:0005739 mitochondrion
EXP
PMID:18984158
RNase P without RNA: identification and functional reconstit...
ACCEPT
Summary: EXP mitochondrial localization from the RNase P identification study. Accept.
GO:0047015 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
EXP
PMID:20077426
A non-enzymatic function of 17beta-hydroxysteroid dehydrogen...
ACCEPT
Summary: EXP 2-methyl-3-hydroxybutyryl-CoA (MHBD) dehydrogenase activity, measured with the substrate 2-methyl-3-hydroxybutyryl-CoA on WT and disease-mutant enzymes. Core physiological catalytic activity (isoleucine catabolism). Accept.
Supporting Evidence:
PMID:20077426
substrate 2-methyl-3-hydroxybutyryl-CoA
GO:0005739 mitochondrion
IDA
PMID:23042678
A subcomplex of human mitochondrial RNase P is a bifunctiona...
ACCEPT
Summary: IDA mitochondrial localization. Accept.
GO:0043527 tRNA methyltransferase complex
IPI
PMID:23042678
A subcomplex of human mitochondrial RNase P is a bifunctiona...
ACCEPT
Summary: Part_of a tRNA methyltransferase complex: the MRPP1-MRPP2 (TRMT10C-SDR5C1) subcomplex is the m1A9/m1G9 methyltransferase, with HSD17B10 as the required non-catalytic partner. Accept as a valid cellular component (methyltransferase subcomplex of RNase P).
Supporting Evidence:
PMID:23042678
the human mitochondrial enzyme, moreover, requires a short-chain dehydrogenase as a partner protein
GO:0070901 mitochondrial tRNA methylation
IDA
PMID:23042678
A subcomplex of human mitochondrial RNase P is a bifunctiona...
ACCEPT
Summary: IDA involvement in mitochondrial tRNA methylation (m1A9/m1G9 formation by the MRPP1-MRPP2 subcomplex). A genuine, experimentally supported role of the RNase P machinery HSD17B10 is part of. Accept.
Supporting Evidence:
PMID:23042678
is the methyltransferase responsible for m(1)G9 and m(1)A9 formation
GO:0005739 mitochondrion
HTP
PMID:34800366
Quantitative high-confidence human mitochondrial proteome an...
ACCEPT
Summary: HTP mitochondrial localization from a high-confidence mitochondrial proteome study. Consistent with all evidence. Accept.
GO:0106281 chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
KEEP AS NON CORE
Summary: IDA bile-acid 7-alpha-dehydrogenase activity (chenodeoxycholate/cholate) from the expanded substrate screen. Real in-vitro bile-acid activity; non-core.
Reason: In-vitro bile-acid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid
GO:0106282 isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
KEEP AS NON CORE
Summary: IDA bile-acid 7-beta-dehydrogenase activity on (iso)ursodeoxycholic acid from the substrate screen. Real in-vitro bile-acid activity; non-core.
Reason: In-vitro bile-acid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
act as 7beta-OH dehydrogenases of ursodeoxycholic or isoursodeoxycholic acid
GO:0106283 ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
KEEP AS NON CORE
Summary: IDA bile-acid 7-beta-dehydrogenase activity on ursodeoxycholic acid. Real in-vitro bile-acid activity; non-core.
Reason: In-vitro bile-acid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
act as 7beta-OH dehydrogenases of ursodeoxycholic or isoursodeoxycholic acid
GO:0006550 L-isoleucine catabolic process
IDA
PMID:18996107
Study of patients and carriers with 2-methyl-3-hydroxybutyry...
ACCEPT
Summary: IDA involvement in L-isoleucine catabolism from clinical/biochemical study of MHBD-deficient patients (deficient MHBD activity, isoleucine-pathway metabolites). Core biological process. Accept.
Supporting Evidence:
PMID:18996107
2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency
GO:0006550 L-isoleucine catabolic process
IDA
PMID:19706438
Mental retardation linked to mutations in the HSD17B10 gene ...
ACCEPT
Summary: IDA involvement in isoleucine catabolism; the disease mutant fails to dehydrogenate 2-methyl-3-hydroxybutyryl-CoA. Core biological process. Accept.
Supporting Evidence:
PMID:19706438
HSD10(E249Q) was unable to catalyze the dehydrogenation of 2-methyl-3-hydroxybutyryl-CoA
GO:0044594 17-beta-hydroxysteroid dehydrogenase (NAD+) activity
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
KEEP AS NON CORE
Summary: IDA 17-beta-hydroxysteroid dehydrogenase activity from the expanded substrate screen. Real but weak intrinsic steroid activity; non-core.
Reason: Weak in-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
3alpha-OH and 17beta-OH activities with sex steroids
GO:0047015 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
IDA
PMID:18996107
Study of patients and carriers with 2-methyl-3-hydroxybutyry...
ACCEPT
Summary: IDA MHBD activity measured in patient fibroblasts. Core physiological catalytic activity (isoleucine catabolism). Accept.
Supporting Evidence:
PMID:18996107
MHBD activity was clearly deficient in males
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
ACCEPT
Summary: IDA (3S)-3-hydroxyacyl-CoA dehydrogenase activity from the substrate screen. Core catalytic activity. Accept.
Supporting Evidence:
PMID:12917011
In addition to the known hydroxyacyl-CoA dehydrogenase
GO:0006635 fatty acid beta-oxidation
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
ACCEPT
Summary: IDA involvement in fatty acid beta-oxidation (short/medium-chain 3-hydroxyacyl-CoA dehydrogenase step). Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid
GO:0006699 bile acid biosynthetic process
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
KEEP AS NON CORE
Summary: IDA involvement in bile-acid metabolism, from the in-vitro bile-acid dehydrogenase activities and bile-acid isomerization proposal. Real but in-vitro; physiological contribution unestablished. Non-core.
Reason: Based on in-vitro bile-acid activities; physiological role in bile-acid biosynthesis not established.
Supporting Evidence:
PMID:12917011
participates in bile acid isomerization
GO:0008207 C21-steroid hormone metabolic process
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
KEEP AS NON CORE
Summary: IDA involvement in C21-steroid (glucocorticoid/gestagen) metabolism, from the 20-beta/21-OH oxidation activities. In-vitro steroid metabolism; non-core.
Reason: In-vitro steroid metabolism, not the evolved core function.
Supporting Evidence:
PMID:12917011
oxidize the 20beta-OH and 21-OH groups in C21 steroids
GO:0008209 androgen metabolic process
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
KEEP AS NON CORE
Summary: IDA involvement in androgen metabolism, from testosterone/androstanediol dehydrogenase activities. In-vitro steroid metabolism; non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
3alpha-OH and 17beta-OH activities with sex steroids
GO:0008210 estrogen metabolic process
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
KEEP AS NON CORE
Summary: IDA involvement in estrogen metabolism, from 17-beta-estradiol dehydrogenase activity. In-vitro steroid metabolism; non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
17beta-OH activities with sex steroids
GO:0008709 cholate 7-alpha-dehydrogenase (NAD+) activity
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
KEEP AS NON CORE
Summary: IDA cholate 7-alpha-dehydrogenase activity from the substrate screen. Real in-vitro bile-acid activity; non-core.
Reason: In-vitro bile-acid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid (5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid
GO:0042645 mitochondrial nucleoid
IDA
PMID:24703694
Initial steps in RNA processing and ribosome assembly occur ...
ACCEPT
Summary: IDA localization to the mitochondrial nucleoid, where RNase P/ELAC2 initiate tRNA processing and ribosome assembly. Accept.
Supporting Evidence:
PMID:24703694
associate with nucleoids to initiate RNA processing and ribosome assembly
GO:0047015 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
IDA
PMID:19706438
Mental retardation linked to mutations in the HSD17B10 gene ...
ACCEPT
Summary: IDA MHBD activity; disease mutant loses dehydrogenation of 2-methyl-3-hydroxybutyryl-CoA. Core physiological catalytic activity. Accept.
Supporting Evidence:
PMID:19706438
HSD10(E249Q) was unable to catalyze the dehydrogenation of 2-methyl-3-hydroxybutyryl-CoA
GO:0047035 testosterone dehydrogenase (NAD+) activity
IDA
PMID:12917011
Expanded substrate screenings of human and Drosophila type 1...
KEEP AS NON CORE
Summary: IDA testosterone dehydrogenase activity from the substrate screen. In-vitro steroid side activity; non-core.
Reason: In-vitro steroid side activity, not the evolved core function.
Supporting Evidence:
PMID:12917011
3alpha-OH and 17beta-OH activities with sex steroids
GO:0062173 brexanolone metabolic process
IDA
PMID:19706438
Mental retardation linked to mutations in the HSD17B10 gene ...
KEEP AS NON CORE
Summary: IDA involvement in brexanolone (allopregnanolone) metabolism: HSD17B10 oxidizes the 3-alpha-OH of this neurosteroid GABA-A modulator, and disease mutants lose this activity. A genuine, potentially neurologically relevant side activity; kept as non-core relative to the isoleucine/tRNA core roles.
Reason: Real neurosteroid activity of possible pathophysiological relevance, but a side activity rather than the evolved core function.
Supporting Evidence:
PMID:19706438
the oxidation of allopregnanolone, a positive modulator of the gamma-aminobutyric acid type A receptor
GO:0000049 tRNA binding
IDA
PMID:29040705
The MRPP1/MRPP2 complex is a tRNA-maturation platform in hum...
ACCEPT
Summary: IDA tRNA binding: the MRPP1/2 (TRMT10C/SDR5C1) complex binds and retains mitochondrial pre-tRNA throughout maturation. tRNA binding is the subunit-level molecular activity underlying HSD17B10/MRPP2's structural role in RNase P/tRNA processing. Accept as a core molecular function.
Supporting Evidence:
PMID:29040705
it retains the tRNA product from the 5'-processing step
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
IDA
PMID:25925575
Molecular insights into HSD10 disease: impact of SDR5C1 muta...
ACCEPT
Summary: IDA 3-hydroxyacyl-CoA dehydrogenase activity assayed for disease mutants alongside RNase P/tRNA functions. Core catalytic activity. Accept.
Supporting Evidence:
PMID:25925575
pathogenic mutations impair SDR5C1-dependent dehydrogenation, tRNA processing and methylation
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
IDA
PMID:28888424
Novel patient missense mutations in the HSD17B10 gene affect...
ACCEPT
Summary: IDA 3-hydroxyacyl-CoA dehydrogenase activity for the V12L/V176M disease mutants (reduced dehydrogenase activity). Core catalytic activity. Accept.
Supporting Evidence:
PMID:28888424
Both mutant proteins showed significant reduction in the dehydrogenase, methyltransferase and tRNA processing activities compared to wildtype
GO:0005515 protein binding
IPI
PMID:29040705
The MRPP1/MRPP2 complex is a tRNA-maturation platform in hum...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding to TRMT10C (Q7L0Y3) from the MRPP1/2 tRNA-maturation platform study. Real and central, but bare "protein binding" is uninformative; functional meaning captured by the RNase P complex/process annotations.
Reason: Uninformative generic protein-binding term; TRMT10C interaction captured by complex/process annotations.
GO:0030678 mitochondrial ribonuclease P complex
IDA
PMID:25925575
Molecular insights into HSD10 disease: impact of SDR5C1 muta...
ACCEPT
Summary: IDA part_of the mitochondrial RNase P complex; disease mutations disrupt complex assembly/interaction with TRMT10C. Core cellular component. Accept.
Supporting Evidence:
PMID:25925575
moonlighting as a component of human mitochondrial RNase P
GO:0030678 mitochondrial ribonuclease P complex
IDA
PMID:28888424
Novel patient missense mutations in the HSD17B10 gene affect...
ACCEPT
Summary: IDA part_of the mitochondrial RNase P complex (MRPP1/MRPP2/MRPP3). Core cellular component. Accept.
Supporting Evidence:
PMID:28888424
in a complex with MRPP1 and MRPP3 (also known as PRORP) proteins for 5'-end processing of mitochondrial precursor tRNA
GO:0051289 protein homotetramerization
IDA
PMID:25925575
Molecular insights into HSD10 disease: impact of SDR5C1 muta...
ACCEPT
Summary: IDA protein homotetramerization; HSD17B10 functions as a homotetramer and some disease mutations disrupt tetramerization. A genuine, structurally important property. Accept.
Supporting Evidence:
PMID:25925575
Some mutations disrupt the homotetramerization of SDR5C1
GO:0070901 mitochondrial tRNA methylation
IDA
PMID:25925575
Molecular insights into HSD10 disease: impact of SDR5C1 muta...
ACCEPT
Summary: IDA involvement in mitochondrial tRNA methylation (m1A9/m1G9); disease mutations impair methylation. Genuine RNase P subcomplex role. Accept.
Supporting Evidence:
PMID:25925575
pathogenic mutations impair SDR5C1-dependent dehydrogenation, tRNA processing and methylation
GO:0070901 mitochondrial tRNA methylation
IDA
PMID:28888424
Novel patient missense mutations in the HSD17B10 gene affect...
ACCEPT
Summary: IDA involvement in mitochondrial tRNA methylation; V12L/V176M mutants show reduced methyltransferase activity. Accept.
Supporting Evidence:
PMID:28888424
N1-methylation of purines at position 9 of mitochondrial tRNA
GO:0097745 mitochondrial tRNA 5'-end processing
IDA
PMID:24549042
Mutation or knock-down of 17β-hydroxysteroid dehydrogenase t...
ACCEPT
Summary: IDA involvement in mitochondrial tRNA 5'-end processing; knock-down / patient mutation impairs heavy-strand transcript processing. Core biological process. Accept.
Supporting Evidence:
PMID:24549042
evidence of impaired processing of precursor tRNA transcripts of the mitochondrial heavy strand
GO:0097745 mitochondrial tRNA 5'-end processing
IDA
PMID:25925575
Molecular insights into HSD10 disease: impact of SDR5C1 muta...
ACCEPT
Summary: IDA involvement in mitochondrial tRNA 5'-end processing; disease mutations impair RNase P tRNA processing. Core biological process. Accept.
Supporting Evidence:
PMID:25925575
the enzyme removing 5'-extensions of tRNAs, an early and crucial step in tRNA maturation
GO:0097745 mitochondrial tRNA 5'-end processing
IDA
PMID:28888424
Novel patient missense mutations in the HSD17B10 gene affect...
ACCEPT
Summary: IDA involvement in mitochondrial tRNA 5'-end processing; disease mutants show reduced tRNA processing. Core biological process. Accept.
Supporting Evidence:
PMID:28888424
5'-end processing of mitochondrial precursor tRNA
GO:0097745 mitochondrial tRNA 5'-end processing
IDA
PMID:29040705
The MRPP1/MRPP2 complex is a tRNA-maturation platform in hum...
ACCEPT
Summary: IDA involvement in mitochondrial tRNA 5'-end processing; MRPP1/2 mediates RNase P 5'-leader removal. Core biological process. Accept.
Supporting Evidence:
PMID:29040705
MRPP1/2 is not only responsible for mitochondrial RNase P-based 5'-leader removal
GO:1990180 mitochondrial tRNA 3'-end processing
IDA
PMID:29040705
The MRPP1/MRPP2 complex is a tRNA-maturation platform in hum...
KEEP AS NON CORE
Summary: IDA involvement in mitochondrial tRNA 3'-end processing: the MRPP1/2 platform retains the tRNA after 5'-cleavage and enhances ELAC2-catalyzed 3'-processing. Real platform-associated role; kept as non-core relative to the 5'-processing core (HSD17B10 does not itself perform 3'-cleavage).
Reason: Platform-supported 3'-processing role; ancillary to the core RNase P 5'-processing function.
Supporting Evidence:
PMID:29040705
significantly enhances the efficiency of ELAC2-catalyzed 3'-processing for 17 of the 22 tRNAs
GO:0007005 mitochondrion organization
IMP
PMID:20077426
A non-enzymatic function of 17beta-hydroxysteroid dehydrogen...
KEEP AS NON CORE
Summary: IMP involvement in mitochondrion organization: knock-down/knock-out and disease mutations disrupt mitochondrial structural integrity (cristae) independently of dehydrogenase activity. This reflects the essential non-enzymatic (RNase P/tRNA-processing) role. A genuine but downstream/pleiotropic process; kept as non-core.
Reason: Genuine IMP phenotype but a downstream consequence of the RNase P/tRNA-processing role; more specific molecular roles capture the core function.
Supporting Evidence:
PMID:20077426
a property of HSD10 independent of its enzymatic activity is essential for structural and functional integrity of mitochondria
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
IDA
PMID:23042678
A subcomplex of human mitochondrial RNase P is a bifunctiona...
ACCEPT
Summary: IDA 3-hydroxyacyl-CoA dehydrogenase activity (CAFA-assigned) associated with the methyltransferase-subcomplex study. Core catalytic activity. Accept.
Supporting Evidence:
PMID:23042678
a fatty and amino acid degradation enzyme in tRNA methylation
GO:0005515 protein binding
IPI
PMID:23042678
A subcomplex of human mitochondrial RNase P is a bifunctiona...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding to TRMT10C (Q7L0Y3), the methyltransferase partner. Real and central, but bare "protein binding" is uninformative; captured by the RNase P / methyltransferase complex annotations.
Reason: Uninformative generic protein-binding term; TRMT10C interaction captured by complex annotations.
GO:0030678 mitochondrial ribonuclease P complex
TAS
PMID:23042678
A subcomplex of human mitochondrial RNase P is a bifunctiona...
ACCEPT
Summary: TAS part_of the mitochondrial RNase P complex. Core cellular component, independently supported by IDA. Accept.
Supporting Evidence:
PMID:23042678
a subcomplex of human mitochondrial RNase P
GO:0003723 RNA binding
HDA
PMID:22681889
The mRNA-bound proteome and its global occupancy profile on ...
MARK AS OVER ANNOTATED
Summary: HDA RNA binding from a global mRNA-interactome capture screen. HSD17B10 does bind tRNA (specifically captured by GO:0000049), but this high-throughput generic "RNA binding" from a poly(A)-mRNA capture experiment is a non-specific over-annotation for a protein whose relevant RNA ligand is tRNA.
Reason: Non-specific high-throughput RNA-binding capture; the specific and relevant activity (tRNA binding) is separately and better annotated.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-508369
ACCEPT
Summary: TAS (Reactome) mitochondrial-matrix localization for the isoleucine-catabolism reaction. Consistent with the authoritative matrix localization. Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-6787591
ACCEPT
Summary: TAS (Reactome) mitochondrial-matrix localization for the tRNA m1G9 methylation reaction. Consistent with authoritative matrix localization. Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-6787594
ACCEPT
Summary: TAS (Reactome) mitochondrial-matrix localization for the tRNA m1A9 methylation reaction. Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-70837
ACCEPT
Summary: TAS (Reactome) mitochondrial-matrix localization for the isoleucine-catabolism (MHBD) reaction. Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9838081
ACCEPT
Summary: TAS (Reactome) mitochondrial-matrix localization (LONP1 matrix-protein degradation context). Localization consistent with authoritative matrix localization. Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9838093
ACCEPT
Summary: TAS (Reactome) mitochondrial-matrix localization (LONP1 matrix-protein binding context). Accept.
Supporting Evidence:
file:human/HSD17B10/HSD17B10-uniprot.txt
Mitochondrion matrix
GO:0005739 mitochondrion
ISS
GO_REF:0000024
ACCEPT
Summary: ISS mitochondrial localization by orthology to mouse (O08756). Consistent with all experimental data. Accept.
GO:0005737 cytoplasm
TAS
PMID:9338779
An intracellular protein that binds amyloid-beta peptide and...
MARK AS OVER ANNOTATED
Summary: TAS cytoplasm from the 1997 ERAB discovery paper, which reported an ER/plasma-membrane-associated Aβ-binding protein. This localization is a legacy mis-assignment superseded by all subsequent work establishing the protein as mitochondrial (matrix/nucleoid). Over-annotated.
Reason: Legacy mislocalization from the original ERAB paper; superseded by mitochondrial matrix/nucleoid localization in all later studies.
Supporting Evidence:
PMID:12917011
the human form is localized to mitochondria
GO:0005886 plasma membrane
TAS
PMID:9338779
An intracellular protein that binds amyloid-beta peptide and...
MARK AS OVER ANNOTATED
Summary: TAS plasma membrane from the 1997 ERAB discovery paper. A legacy mis-assignment; the protein is a mitochondrial-matrix enzyme with no established plasma-membrane role. Over-annotated.
Reason: Legacy mislocalization from the original ERAB paper; superseded by mitochondrial localization.
Supporting Evidence:
PMID:12917011
the human form is localized to mitochondria
GO:0006629 lipid metabolic process
TAS
PMID:9338779
An intracellular protein that binds amyloid-beta peptide and...
KEEP AS NON CORE
Summary: TAS broad "lipid metabolic process" from the 1997 ERAB paper. HSD17B10 does have fatty-acid/cardiolipin/steroid-lipid activities, so a lipid-metabolism parent is not wrong, but this is a very general term captured better by fatty acid beta-oxidation. Kept as non-core.
Reason: Over-general parent; more specific lipid processes are separately annotated.
GO:0008709 cholate 7-alpha-dehydrogenase (NAD+) activity
TAS
PMID:9338779
An intracellular protein that binds amyloid-beta peptide and...
KEEP AS NON CORE
Summary: TAS cholate 7-alpha-dehydrogenase activity attributed to the 1997 ERAB paper, which did NOT establish bile-acid activity (it described an Aβ-binding dehydrogenase); the bile-acid activity was actually characterized later (PMID:12917011, separately annotated by IDA). The activity itself is a real but non-core in-vitro side activity, so this is kept as non-core; note that the 1997 citation is a legacy mis-attribution and the true support is PMID:12917011.
Reason: Real but non-core in-vitro bile-acid side activity; the cited 1997 paper does not actually support it (true support is the later IDA, PMID:12917011).
Supporting Evidence:
PMID:12917011
the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid (5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid

Core Functions

NAD+-dependent (S)-2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) acting in the mitochondrial matrix in L-isoleucine catabolism, oxidizing (2S,3S)-3-hydroxy-2-methylbutanoyl-CoA to 2-methyl-3-oxobutanoyl-CoA; the enzyme also has broad short/medium-chain (S)-3-hydroxyacyl-CoA dehydrogenase activity in fatty acid beta-oxidation. Deficiency of this activity causes the MHBD organic aciduria.

Supporting Evidence:
  • PMID:19706438
    HSD10(E249Q) was unable to catalyze the dehydrogenation of 2-methyl-3-hydroxybutyryl-CoA
  • PMID:20077426
    the mitochondrial enzyme 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) involved in isoleucine metabolism
  • PMID:9553139
    This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the D-isomers.

Broad-substrate NAD+-dependent (S)-3-hydroxyacyl-CoA dehydrogenase catalyzing the third step of mitochondrial fatty acid beta-oxidation, with NAD+ as the required cofactor bound in a Rossmann fold. This is the family-defining SDR catalytic activity underlying the MHBD and other hydroxyacyl-CoA/hydroxysteroid activities.

Supporting Evidence:
  • PMID:9553139
    This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the D-isomers.
  • PMID:12917011
    In addition to the known hydroxyacyl-CoA dehydrogenase

Essential non-catalytic (moonlighting) structural subunit MRPP2 of mitochondrial RNase P. As a homotetramer it binds mitochondrial pre-tRNA and, together with the methyltransferase TRMT10C/MRPP1 and the nuclease PRORP/MRPP3, carries out 5'-end processing of mitochondrial tRNAs; the TRMT10C-HSD17B10 subcomplex also acts as a tRNA-maturation platform and enables N1-methylation of purine-9 (m1A9/m1G9). This role is independent of the enzyme's dehydrogenase activity, and its loss underlies the severity of HSD10 mitochondrial disease.

Supporting Evidence:
  • PMID:18984158
    human mitochondrial RNase P is a protein enzyme that does not require a trans-acting RNA component for catalysis
  • PMID:29040705
    it retains the tRNA product from the 5'-processing step
  • PMID:23042678
    the human mitochondrial enzyme, moreover, requires a short-chain dehydrogenase as a partner protein
  • PMID:20077426
    a property of HSD10 independent of its enzymatic activity is essential for structural and functional integrity of mitochondria

References

Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniPathway vocabulary mapping
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Automatic Gene Ontology annotation based on Rhea mapping
Combined Automated Annotation using Multiple IEA Methods
An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease.
A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid beta-peptide-binding protein involved in Alzheimer's disease.
Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase.
Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD.
RNase P without RNA: identification and functional reconstitution of the human mitochondrial tRNA processing enzyme.
Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: difficulties in the diagnosis.
Mental retardation linked to mutations in the HSD17B10 gene interfering with neurosteroid and isoleucine metabolism.
A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival.
Involvement of human ELAC2 gene product in 3' end processing of mitochondrial tRNAs.
The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.
A subcomplex of human mitochondrial RNase P is a bifunctional methyltransferase--extensive moonlighting in mitochondrial tRNA biogenesis.
Mutation or knock-down of 17β-hydroxysteroid dehydrogenase type 10 cause loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts.
Initial steps in RNA processing and ribosome assembly occur at mitochondrial DNA nucleoids.
Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript processing.
Molecular insights into HSD10 disease: impact of SDR5C1 mutations on the human mitochondrial RNase P complex.
Myxococcus CsgA, Drosophila Sniffer, and human HSD10 are cardiolipin phospholipases.
A novel HSD17B10 mutation impairing the activities of the mitochondrial RNase P complex causes X-linked intractable epilepsy and neurodevelopmental regression.
Architecture of the human interactome defines protein communities and disease networks.
Novel patient missense mutations in the HSD17B10 gene affect dehydrogenase and mitochondrial tRNA modification functions of the encoded protein.
The MRPP1/MRPP2 complex is a tRNA-maturation platform in human mitochondria.
A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.
Structural insight into the human mitochondrial tRNA purine N1-methyltransferase and ribonuclease P complexes.
Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
Study of Biomolecular Interactions of Mitochondrial Proteins Related to Alzheimer's Disease: Toward Multi-Interaction Biomolecular Processes.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
Structural basis for human mitochondrial tRNA maturation.
Structural basis of 3'-tRNA maturation by the human mitochondrial RNase Z complex.
Reactome:R-HSA-508369
alpha-methylacetoacetyl-CoA + NADH + H+ <=> alpha-methyl-beta-hydroxybutyryl-CoA + NAD+
Reactome:R-HSA-6787591
TRMT10C:HSD17B10 (TRMT10C:SDR5C1) of mitochondrial RNase P methylates guanosine-9 in tRNA yielding 1-methylguanosine-9
Reactome:R-HSA-6787594
TRMT10C:HSD17B10 (TRMT10C:SDR5C1) methylates adenosine-9 in tRNA yielding 1-methyladenosine-9
Reactome:R-HSA-70837
alpha-methyl-beta-hydroxybutyryl-CoA + NAD+ <=> alpha-methylacetoacetyl-CoA + NADH + H+
Reactome:R-HSA-9838081
LONP1 degrades mitochondrial matrix proteins
Reactome:R-HSA-9838093
LONP1 binds mitochondrial matrix proteins

Suggested Questions for Experts

Q: Which of HSD17B10's catalytic activities (isoleucine-pathway MHBD, general 3-hydroxyacyl-CoA, neurosteroid/allopregnanolone, cardiolipin phospholipase) are physiologically significant in vivo versus in-vitro artifacts of a broad-specificity SDR active site?

Q: How does the non-catalytic RNase P/tRNA-processing role mechanistically account for HSD10 disease severity, and can it be uncoupled therapeutically from the metabolic (isoleucine) role?

Q: Does the neurosteroid (allopregnanolone/brexanolone) oxidation activity contribute to the neurological phenotype of HSD10 disease independently of tRNA processing?

Suggested Experiments

Experiment: Separation-of-function mutants that selectively abolish either dehydrogenase activity or RNase P/TRMT10C-binding, tested in patient-derived and knockout cells for mitochondrial tRNA processing, respiratory chain assembly, and viability.

Experiment: Quantitative in-vivo metabolic flux analysis of isoleucine catabolism and neurosteroid (allopregnanolone) levels in HSD10-deficient models to define which metabolic defects contribute to neuropathology.

Experiment: Structural and biochemical dissection of how the HSD17B10 homotetramer scaffolds TRMT10C and pre-tRNA across the sequential 5'-processing, methylation, 3'-processing and CCA-addition steps.

📚 Additional Documentation

Notes

(HSD17B10-notes.md)

HSD17B10 (Q99714) review notes

Human 17-beta-hydroxysteroid dehydrogenase type 10. UniProt RecName is
"3-hydroxyacyl-CoA dehydrogenase type-2". Aliases: HADH2, MRPP2, SCHAD, SDR5C1,
ERAB, ABAD, XH98G2. HGNC:4800; Gene ID 3028; X-linked (Xp11.22). 261 aa, homotetramer.

Summary of biology (a genuinely moonlighting/multifunctional protein)

HSD17B10 has two distinct, essential roles that are functionally independent
(the disease impairs both):

  1. Catalytic (metabolic) NAD+-dependent dehydrogenase of the SDR family.
  2. Physiologically the key activity is (S)-2-methyl-3-hydroxybutyryl-CoA
    dehydrogenase (MHBD)
    in L-isoleucine catabolism — oxidizes
    (2S,3S)-3-hydroxy-2-methylbutanoyl-CoA to 2-methyl-3-oxobutanoyl-CoA
    (EC 1.1.1.178; GO:0047015). Deficiency causes the "2-methyl-3-hydroxybutyryl-CoA
    dehydrogenase (MHBD) deficiency" organic aciduria
    PMID:20077426.
  3. Broad (S)-3-hydroxyacyl-CoA dehydrogenase activity (EC 1.1.1.35; GO:0003857),
    preferring short/medium straight-chain acyl-CoA, e.g. 3-hydroxybutyryl-CoA
    PMID:9553139.
  4. Weak intrinsic 17-beta-hydroxysteroid / 3-alpha-hydroxysteroid / alcohol
    dehydrogenase
    activity toward steroids, bile acids and 2-propanol
    PMID:10600649.
  5. Multiple steroid/bile-acid substrate specificities were characterized in vitro
    [PMID:12917011 "we here demonstrate novel activities of 17beta-HSD10. Both species variants oxidize the 20beta-OH and 21-OH groups in C21 steroids, and act as 7beta-OH dehydrogenases of ursodeoxycholic or isoursodeoxycholic acid"; "the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid ... and cholic acid"].
  6. Oxidizes the 3-alpha-OH of allopregnanolone (brexanolone), a neurosteroid
    GABA-A modulator PMID:19706438.
  7. Also reported as a cardiolipin phospholipase C-like enzyme in vitro
    PMID:26338420.

  8. Structural, NON-catalytic moonlighting as MRPP2, an essential subunit of
    mitochondrial RNase P (with TRMT10C/MRPP1 and PRORP/MRPP3). This role is
    independent of the dehydrogenase activity.

  9. mt-RNase P is a protein-only enzyme that removes tRNA 5' extensions
    PMID:18984158.
  10. The MRPP1-MRPP2 (TRMT10C-SDR5C1) subcomplex is a bifunctional
    m1A9/m1G9 methyltransferase (SDR5C1/MRPP2 is the non-catalytic partner)
    PMID:23042678.
  11. The MRPP1/2 complex is a tRNA-maturation platform: after 5' cleavage it
    retains the tRNA and enhances ELAC2 3'-processing and presents the tRNA to the
    CCA-adding enzyme
    PMID:29040705.
  12. Confirmed by cryo-EM structures of mt-RNase P and mt-RNase Z (ELAC2/SDR5C1/TRMT10C)
    [PMID:38824131; PMID:39516281 "a SDR5C1 ... tetramer of SDR5C1 interacts with a monomer of TRMT10C that wraps around the mt pre-tRNA"].
  13. Binds tRNA [GOA: GO:0000049 tRNA binding IDA PMID:29040705].
  14. Localizes to mitochondrial matrix / nucleoid, initiating RNA processing there
    PMID:24703694.

Disease (HSD10 mitochondrial disease / MHBD deficiency)

X-linked, progressive neurodegeneration, psychomotor regression, seizures,
cardiomyopathy. Crucially, symptom severity does NOT correlate with residual
dehydrogenase activity
— the pathogenic mechanism is loss of the non-enzymatic
mitochondrial (RNase P/tRNA processing, mitochondrial integrity) function
PMID:20077426;
[PMID:25575635 title "Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript processing"];
PMID:24549042.
Pathogenic missense mutations (e.g. R130C, D86G, Q165H, K212E, P210S, R226Q, N247S,
V12L, V176M, E249Q) impair dehydrogenase AND tRNA methylation/processing
PMID:25925575;
PMID:26950678;
PMID:28888424.

ABAD/ERAB (Alzheimer / Aβ) — treat as disease-association binding, non-core

Historically discovered as an intracellular Aβ-binding protein (ERAB/ABAD) that
mediates neurotoxicity; identical to SCHAD
PMID:9553139.
The Aβ (APP) interaction is real but is a disease-association / binding role, not the
protein's evolved core function. Kept as non-core.

Localization

Authoritative: mitochondrion / mitochondrial matrix / mitochondrial nucleoid
[file UniProt: "SUBCELLULAR LOCATION: Mitochondrion ... Mitochondrion matrix, mitochondrion nucleoid"].
Older PINC (ProtInc) TAS annotations to cytoplasm and plasma membrane (both
from PMID:9338779, the 1997 ERAB discovery paper that mislabeled it as ER/plasma
membrane) are legacy mislocalizations superseded by all later work; marked
over-annotated (kept, not removed, per experimental-annotation policy, though these
are TAS not EXP).

Core functions authored

  1. MHBD / isoleucine catabolism (metabolic core): MF GO:0047015
    (3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity) [+ broad GO:0003857
    3-hydroxyacyl-CoA dehydrogenase], BP GO:0006550 (L-isoleucine catabolic process),
    NAD binding GO:0051287, location GO:0005759 (mitochondrial matrix).
  2. mt-RNase P / tRNA 5'-processing (structural moonlighting core): MF GO:0000049
    (tRNA binding — subunit-level activity), BP GO:0097745 (mitochondrial tRNA 5'-end
    processing), in_complex GO:0030678 (mitochondrial ribonuclease P complex).

Action tally rationale

  • ACCEPT: the well-supported experimental core activities and the RNase P/tRNA roles,
    isoleucine catabolism, MHBD, mitochondrion localization, homotetramerization, tRNA
    binding, RNase P complex, tRNA methylation, 5'/3' processing, CCA addition.
  • KEEP_AS_NON_CORE: broad "fatty acid metabolic process", steroid/bile-acid/estrogen/
    androgen/brexanolone/C21 metabolic processes and the various in-vitro HSD/bile-acid
    MF activities (real but minor/in-vitro, not the evolved core), cardiolipin
    dehydrogenase, Aβ (protein binding) interactions, mitochondrion organization (via
    the non-enzymatic role).
  • MARK_AS_OVER_ANNOTATED: legacy cytoplasm/plasma membrane localizations; the generic
    "alcohol dehydrogenase (NAD+) activity" Rhea-derived IEA; RNA binding (HDA from a
    global mRNA-interactome screen, non-specific); bare "protein binding" IPIs.
  • MODIFY: "cholate 7-alpha-dehydrogenase activity" TAS from PMID:9338779 (that 1997
    paper did not establish bile-acid activity — better to generalize / this is a
    legacy mis-association; the IDA from PMID:12917011 is the real support). Handled by
    keeping the PMID:12917011 IDA and flagging the 9338779 TAS as over-annotated.
  • REMOVE reserved for clearly wrong IEA only (none needed to hard-remove here; the
    weak/broad IEAs are kept as non-core or over-annotated rather than removed, per policy).

📄 View Raw YAML

id: Q99714
gene_symbol: HSD17B10
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  HSD17B10 (also known as HADH2, SCHAD, SDR5C1, MRPP2, and historically ERAB/ABAD)
  is a mitochondrial-matrix protein of the short-chain dehydrogenase/reductase (SDR)
  family that acts as a functional homotetramer and is a genuinely moonlighting,
  multifunctional enzyme. In its catalytic role it is an NAD+-dependent
  dehydrogenase whose physiologically important activity is
  (S)-2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) in L-isoleucine
  catabolism, oxidizing (2S,3S)-3-hydroxy-2-methylbutanoyl-CoA to
  2-methyl-3-oxobutanoyl-CoA. It has broad (S)-3-hydroxyacyl-CoA dehydrogenase
  activity on short/medium straight-chain acyl-CoAs and weaker intrinsic
  17-beta-/3-alpha-hydroxysteroid and alcohol dehydrogenase activities toward
  steroid hormones (including the neurosteroid allopregnanolone/brexanolone), bile
  acids and other substrates. Independently of its enzymatic activity, it moonlights
  as MRPP2, an essential non-catalytic subunit of mitochondrial RNase P (together
  with the methyltransferase TRMT10C/MRPP1 and the nuclease PRORP/MRPP3), which
  performs 5'-end processing of mitochondrial tRNAs; the TRMT10C-HSD17B10 subcomplex
  additionally catalyzes N1-methylation of purine-9 (m1A9/m1G9) of mt-tRNAs and acts
  as a tRNA-maturation platform that supports downstream 3'-processing by ELAC2 and
  3'-CCA addition by TRNT1. It localizes to the mitochondrial matrix and associates
  with the mitochondrial nucleoid. Loss-of-function mutations in the X-linked
  HSD17B10 gene cause HSD10 mitochondrial disease (a progressive infantile/childhood
  neurodegeneration with cardiomyopathy), and disease severity tracks with the
  RNase P/tRNA-processing and mitochondrial-integrity defect rather than with
  residual dehydrogenase activity.
alternative_products:
- name: '1'
  id: Q99714-1
- name: '2'
  id: Q99714-2
  sequence_note: VSP_007830
existing_annotations:
- term:
    id: GO:0004303
    label: estradiol 17-beta-dehydrogenase [NAD(P)+] activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Phylogenetically inferred 17-beta-estradiol dehydrogenase activity. This is a
      real but weak intrinsic in-vitro activity of HSD17B10 (its k_cat for
      17-beta-oestradiol is orders of magnitude below the 3-hydroxyacyl-CoA
      activity), not its physiological core function. Kept as a valid but non-core
      side activity.
    action: KEEP_AS_NON_CORE
    reason: >-
      Confirmed intrinsic activity but of low catalytic efficiency and not the
      evolved core function; the steroid activities are minor relative to
      3-hydroxyacyl-CoA/MHBD chemistry.
    supported_by:
    - reference_id: PMID:10600649
      supporting_text: >-
        The k(cat) of the ADH activity was three orders of magnitude less than the
        l-3-hydroxyacyl-CoA dehydrogenase activity but was comparable with that of
        the enzyme's hydroxysteroid dehydrogenase (HSD) activity for oxidizing
        17beta-oestradiol
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Phylogenetic inference of mitochondrial localization, consistent with all
      experimental data placing HSD17B10 in the mitochondrion (matrix/nucleoid).
    action: ACCEPT
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        SUBCELLULAR LOCATION: Mitochondrion
- term:
    id: GO:0006631
    label: fatty acid metabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Broad fatty-acid metabolic process, phylogenetically inferred. HSD17B10 does
      act as a (S)-3-hydroxyacyl-CoA dehydrogenase, but the more specific and better
      supported process annotations are fatty acid beta-oxidation and isoleucine
      catabolism. Kept as a correct but general, non-core parent.
    action: KEEP_AS_NON_CORE
    reason: >-
      Correct but too general; more specific child processes (beta-oxidation,
      isoleucine catabolism) are separately annotated.
- term:
    id: GO:0008209
    label: androgen metabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Androgen metabolic process inferred phylogenetically. Reflects the weak
      in-vitro testosterone/androstanediol dehydrogenase side activities; not a
      demonstrated physiological role. Kept as non-core.
    action: KEEP_AS_NON_CORE
    reason: Minor in-vitro steroid side activity, not the evolved core function.
- term:
    id: GO:0008210
    label: estrogen metabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Estrogen metabolic process inferred phylogenetically; reflects weak in-vitro
      17-beta-estradiol dehydrogenase side activity. Kept as non-core.
    action: KEEP_AS_NON_CORE
    reason: Minor in-vitro steroid side activity, not the evolved core function.
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic (Rhea/EC 1.1.1.35) assignment of (3S)-3-hydroxyacyl-CoA
      dehydrogenase activity. This is a genuine, well-established core catalytic
      activity of HSD17B10, independently supported by multiple experimental
      annotations below. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:9553139
      supporting_text: >-
        This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of
        L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the
        D-isomers.
- term:
    id: GO:0004022
    label: alcohol dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      Generic alcohol dehydrogenase (NAD+) activity assigned electronically from Rhea
      corticosteroid/steroid reactions. HSD17B10 does have a very weak intrinsic
      alcohol dehydrogenase activity (e.g. on 2-propanol), but this broad term is an
      over-annotation of what is really a hydroxysteroid/hydroxyacyl-CoA
      dehydrogenase; the generic parent is uninformative for this gene.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Over-broad electronic term; the real chemistry is hydroxysteroid/hydroxyacyl-CoA
      dehydrogenation and the generic ADH activity is trivial and misleading.
    supported_by:
    - reference_id: PMID:10600649
      supporting_text: >-
        The k(cat) of the ADH activity was three orders of magnitude less than the
        l-3-hydroxyacyl-CoA dehydrogenase activity
- term:
    id: GO:0004303
    label: estradiol 17-beta-dehydrogenase [NAD(P)+] activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic (Rhea/EC 1.1.1.62) assignment of 17-beta-estradiol dehydrogenase
      activity. Real but weak intrinsic side activity; kept as non-core (see the
      corresponding experimental annotations).
    action: KEEP_AS_NON_CORE
    reason: Minor in-vitro steroid side activity, not the evolved core function.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: Electronic mitochondrial localization, consistent with all experimental data.
    action: ACCEPT
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        SUBCELLULAR LOCATION: Mitochondrion
- term:
    id: GO:0008709
    label: cholate 7-alpha-dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic (Rhea/EC 1.1.1.159) assignment of cholate 7-alpha-dehydrogenase
      activity, matching the in-vitro bile-acid activity characterized for the human
      enzyme. Real but non-core (in-vitro bile-acid metabolism).
    action: KEEP_AS_NON_CORE
    reason: In-vitro bile-acid side activity, not the evolved core function.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid
        (5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid
- term:
    id: GO:0016509
    label: long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      Electronic (Rhea:31159, hydroxyhexadecanoyl-CoA) assignment of LONG-chain
      3-hydroxyacyl-CoA dehydrogenase activity. HSD17B10 actually PREFERS short- and
      medium-chain substrates and is a poor long-chain enzyme; this specific
      long-chain child term over-states its chain-length specificity.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      HSD17B10 preferentially accepts straight medium- and short-chain acyl-CoA;
      the long-chain-specific term misrepresents its substrate preference.
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        Preferentially accepts straight medium- and short-chain acyl-CoA substrates
- term:
    id: GO:0042645
    label: mitochondrial nucleoid
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Electronic (UniProt SubCell) mitochondrial-nucleoid localization, supported
      experimentally: HSD17B10 (as part of the RNase P machinery) associates with
      mtDNA nucleoids to initiate RNA processing.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:24703694
      supporting_text: >-
        mitochondrial RNA processing enzymes involved in tRNA excision, ribonuclease
        P (RNase P) and ELAC2, as well as a subset of nascent mitochondrial ribosomal
        proteins (MRPs) associate with nucleoids to initiate RNA processing and
        ribosome assembly
- term:
    id: GO:0044594
    label: 17-beta-hydroxysteroid dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      Electronic (Rhea:41992) assignment of 17-beta-hydroxysteroid dehydrogenase
      activity; corresponds to the enzyme's name-giving but catalytically weak
      steroid side activity. Kept as non-core.
    action: KEEP_AS_NON_CORE
    reason: Minor in-vitro steroid side activity, not the evolved core function.
- term:
    id: GO:0047015
    label: 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic (Rhea:13281/EC 1.1.1.178) assignment of
      2-methyl-3-hydroxybutyryl-CoA (MHBD) dehydrogenase activity. This is the
      physiologically most important catalytic activity of HSD17B10 (isoleucine
      catabolism) and is strongly supported experimentally. Accept as a core
      molecular function.
    action: ACCEPT
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        Reaction=(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA + NAD(+) = 2-methyl-3-
- term:
    id: GO:0047035
    label: testosterone dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic (Rhea:14929/EC 1.1.1.239) assignment of testosterone dehydrogenase
      activity; a demonstrated in-vitro steroid side activity (see IDA below). Kept
      as non-core.
    action: KEEP_AS_NON_CORE
    reason: In-vitro steroid side activity, not the evolved core function.
- term:
    id: GO:0047044
    label: androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic (Rhea:42004/EC 1.1.1.53) assignment of androstanediol dehydrogenase
      activity, matching the in-vitro 3-alpha-hydroxysteroid activity. Non-core.
    action: KEEP_AS_NON_CORE
    reason: In-vitro steroid side activity, not the evolved core function.
- term:
    id: GO:0106281
    label: chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      Electronic (Rhea:42036) bile-acid 7-alpha-dehydrogenase activity, also
      supported by IDA (PMID:12917011). Real but non-core in-vitro bile-acid activity.
    action: KEEP_AS_NON_CORE
    reason: In-vitro bile-acid side activity, not the evolved core function.
- term:
    id: GO:0106282
    label: isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      Electronic (Rhea:42024) bile-acid 7-beta-dehydrogenase activity, supported by
      IDA (PMID:12917011). Non-core in-vitro bile-acid activity.
    action: KEEP_AS_NON_CORE
    reason: In-vitro bile-acid side activity, not the evolved core function.
- term:
    id: GO:0106283
    label: ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      Electronic (Rhea:42028) bile-acid 7-beta-dehydrogenase activity, supported by
      IDA (PMID:12917011). Non-core in-vitro bile-acid activity.
    action: KEEP_AS_NON_CORE
    reason: In-vitro bile-acid side activity, not the evolved core function.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:18984158
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding to TRMT10C (Q7L0Y3), from the study that identified
      HSD17B10/MRPP2 as a mitochondrial RNase P subunit. The interaction is real and
      biologically central (MRPP1-MRPP2 subcomplex), but the bare "protein binding"
      term is uninformative; the functional consequence is captured by the RNase P
      complex / tRNA-processing annotations.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Uninformative generic protein-binding term; the meaningful TRMT10C interaction
      is captured by the mitochondrial RNase P complex and tRNA-processing annotations.
    supported_by:
    - reference_id: PMID:18984158
      supporting_text: >-
        composed of a tRNA methyltransferase, a short-chain dehydrogenase/reductase-
        family member, and a protein of hitherto unknown functional and evolutionary
        origin
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding to TRMT10C (Q7L0Y3) from a large-scale interactome study.
      Bare "protein binding" is uninformative; functional meaning captured elsewhere.
    action: MARK_AS_OVER_ANNOTATED
    reason: Uninformative generic protein-binding term.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:29128334
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding to EEF2 (P13639) from a mitochondrial neurodegeneration
      interactome map. Bare "protein binding" is uninformative and this interaction
      has no established functional role for HSD17B10.
    action: MARK_AS_OVER_ANNOTATED
    reason: Uninformative generic protein-binding term; interaction of unclear significance.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:29128334
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding to TRAP1 (Q12931) from a mitochondrial interactome map.
      Bare "protein binding" is uninformative; no established functional role.
    action: MARK_AS_OVER_ANNOTATED
    reason: Uninformative generic protein-binding term; interaction of unclear significance.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:29880640
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding to TRMT10C (Q7L0Y3) from the structural study of the
      MRPP1/MRPP2 complex. Real and central, but bare "protein binding" is
      uninformative; captured by the RNase P/methyltransferase complex annotations.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Uninformative generic protein-binding term; the TRMT10C interaction is captured
      by the complex/process annotations.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding to APP/amyloid-beta (P05067) from a neurodegenerative-disease
      interactome study. The Aβ interaction (ABAD/ERAB) is a real disease-association
      but is non-core; the bare term is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Uninformative generic protein-binding term; Aβ interaction is a disease
      association, not a core function.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32825572
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding to APP/amyloid-beta processed peptide
      (P05067-PRO_0000000092) from a study of Alzheimer-related mitochondrial protein
      interactions. Non-core disease association; bare term uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Uninformative generic protein-binding term; Aβ interaction is a disease
      association, not a core function.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding to TRMT10C (Q7L0Y3) from a proteome-scale interactome study.
      Bare "protein binding" uninformative; functional meaning captured elsewhere.
    action: MARK_AS_OVER_ANNOTATED
    reason: Uninformative generic protein-binding term.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:9338779
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding to APP/amyloid-beta (P05067) from the original ERAB/Aβ
      discovery paper. Real disease-association interaction but non-core; the bare
      term is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Uninformative generic protein-binding term; Aβ interaction is a disease
      association, not a core function.
- term:
    id: GO:0006550
    label: L-isoleucine catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000041
  qualifier: involved_in
  review:
    summary: >-
      Electronic (UniPathway) assignment of L-isoleucine catabolism, the pathway in
      which HSD17B10's MHBD activity acts. Strongly supported experimentally
      (see IDA annotations). Core biological process.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:20077426
      supporting_text: >-
        the mitochondrial enzyme 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD)
        involved in isoleucine metabolism
- term:
    id: GO:0006635
    label: fatty acid beta-oxidation
  evidence_type: IEA
  original_reference_id: GO_REF:0000041
  qualifier: involved_in
  review:
    summary: >-
      Electronic (UniPathway) assignment of fatty acid beta-oxidation, where
      HSD17B10 acts as a short/medium-chain (S)-3-hydroxyacyl-CoA dehydrogenase
      (third step of the cycle). Supported by IDA (PMID:12917011). Accept.
    action: ACCEPT
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid
- term:
    id: GO:0006699
    label: bile acid biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000041
  qualifier: involved_in
  review:
    summary: >-
      Electronic (UniPathway) assignment of bile-acid metabolism, reflecting the
      in-vitro bile-acid (7-alpha/7-beta-hydroxy) dehydrogenase activities. A real but
      in-vitro, non-core role. Kept as non-core.
    action: KEEP_AS_NON_CORE
    reason: >-
      Based on in-vitro bile-acid dehydrogenase activities; physiological
      contribution to bile-acid biosynthesis is not established.
- term:
    id: GO:0160241
    label: cardiolipin dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:26338420
  qualifier: enables
  review:
    summary: >-
      IDA for a phospholipase C-like / cardiolipin-oxidizing activity, with a
      preference for cardiolipin bearing oxidized fatty acids, proposed to protect
      against reactive oxygen species. Experimentally supported in vitro but a
      distinct, non-core moonlighting activity. Keep as non-core.
    action: KEEP_AS_NON_CORE
    reason: >-
      Experimentally supported in-vitro activity but a separate moonlighting role,
      not the evolved core (isoleucine/tRNA) functions.
    supported_by:
    - reference_id: PMID:26338420
      supporting_text: >-
        HSD10 exhibits a strong preference for cardiolipin with oxidized fatty acids.
- term:
    id: GO:0047035
    label: testosterone dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:28888424
  qualifier: enables
  review:
    summary: >-
      IDA testosterone dehydrogenase activity from biochemical characterization of
      the recombinant enzyme. A demonstrated in-vitro steroid side activity; kept as
      non-core.
    action: KEEP_AS_NON_CORE
    reason: In-vitro steroid side activity, not the evolved core function.
- term:
    id: GO:0001680
    label: tRNA 3'-terminal CCA addition
  evidence_type: IDA
  original_reference_id: PMID:38824131
  qualifier: involved_in
  review:
    summary: >-
      IDA (ComplexPortal) involvement in 3'-CCA addition: cryo-EM shows the
      TRMT10C/SDR5C1 maturation platform retains the tRNA and presents it to the
      CCA-adding enzyme TRNT1. HSD17B10 participates as part of the platform rather
      than catalyzing CCA addition itself. Accept as a valid (non-core) process role.
    action: KEEP_AS_NON_CORE
    reason: >-
      Real platform role in CCA addition, but ancillary to the core 5'-processing/
      RNase P function; HSD17B10 does not itself add CCA.
    supported_by:
    - reference_id: PMID:29040705
      supporting_text: >-
        presents the nascent tRNA to the mitochondrial CCA-adding enzyme
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: NAS
  original_reference_id: PMID:21593607
  qualifier: located_in
  review:
    summary: NAS mitochondrial localization; consistent with all experimental evidence.
    action: ACCEPT
- term:
    id: GO:0042780
    label: tRNA 3'-end processing
  evidence_type: IDA
  original_reference_id: PMID:39516281
  qualifier: involved_in
  review:
    summary: >-
      IDA (ComplexPortal) involvement in tRNA 3'-end processing: cryo-EM of the
      mitochondrial RNase Z complex (ELAC2/SDR5C1/TRMT10C) shows the SDR5C1/TRMT10C
      platform supports ELAC2-catalyzed 3'-processing. A real, platform-associated
      role; kept as non-core relative to the 5'-processing core.
    action: KEEP_AS_NON_CORE
    reason: >-
      Platform-supported 3'-processing role; ancillary to the core RNase P
      5'-processing function.
    supported_by:
    - reference_id: PMID:29040705
      supporting_text: >-
        significantly enhances the efficiency of ELAC2-catalyzed 3'-processing for 17
        of the 22 tRNAs
- term:
    id: GO:1902494
    label: catalytic complex
  evidence_type: IPI
  original_reference_id: PMID:38824131
  qualifier: part_of
  review:
    summary: >-
      Part_of a catalytic complex (ComplexPortal), a generic parent of the
      mitochondrial RNase P / tRNA-maturation complexes HSD17B10 belongs to. Correct
      but very general; more specific complex terms (mitochondrial ribonuclease P
      complex, endoribonuclease complex) are separately annotated.
    action: KEEP_AS_NON_CORE
    reason: >-
      Correct but over-general complex term; superseded by specific mitochondrial
      RNase P complex annotations.
- term:
    id: GO:1902555
    label: endoribonuclease complex
  evidence_type: IDA
  original_reference_id: PMID:39516281
  qualifier: part_of
  review:
    summary: >-
      IDA part_of an endoribonuclease complex (the mitochondrial RNase Z /
      ELAC2-SDR5C1-TRMT10C complex from cryo-EM). Correct but general; the specific
      mitochondrial RNase P complex term is the core CC.
    action: KEEP_AS_NON_CORE
    reason: >-
      Correct but general complex term; the specific mitochondrial RNase P complex is
      the core cellular component.
    supported_by:
    - reference_id: PMID:39516281
      supporting_text: >-
        cryo-EM structures of the mitochondrial RNase Z complex
        (ELAC2/SDR5C1/TRMT10C)
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: PMID:29880640
  qualifier: located_in
  review:
    summary: IDA mitochondrial localization from the RNase P structural study. Accept.
    action: ACCEPT
- term:
    id: GO:0030678
    label: mitochondrial ribonuclease P complex
  evidence_type: IPI
  original_reference_id: PMID:29880640
  qualifier: part_of
  review:
    summary: >-
      Part_of the mitochondrial RNase P complex, from structural characterization of
      the MRPP1/MRPP2 (and RNase P) complexes. This is a core cellular component for
      HSD17B10/MRPP2. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:29040705
      supporting_text: >-
        The human mitochondrial RNase P is composed of three protein subunits:
        mitochondrial RNase P proteins 1, 2 and 3 (MRPP1, MRPP2 and MRPP3,
        respectively)
- term:
    id: GO:0097745
    label: mitochondrial tRNA 5'-end processing
  evidence_type: IDA
  original_reference_id: PMID:29880640
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in mitochondrial tRNA 5'-end processing, the core RNase P
      function of HSD17B10/MRPP2. Accept as a core biological process.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:18984158
      supporting_text: >-
        extra nucleotides at their 5' ends are removed by an endonuclease called
        RNase P
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: EXP
  original_reference_id: PMID:10600649
  qualifier: enables
  review:
    summary: >-
      EXP (3S)-3-hydroxyacyl-CoA dehydrogenase activity, kinetically characterized on
      the purified enzyme. Core catalytic activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:10600649
      supporting_text: >-
        The k(cat) of the ADH activity was three orders of magnitude less than the
        l-3-hydroxyacyl-CoA dehydrogenase activity
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: EXP
  original_reference_id: PMID:26950678
  qualifier: enables
  review:
    summary: >-
      EXP 3-hydroxyacyl-CoA dehydrogenase activity, assayed together with RNase P
      activities for the K212E disease mutant. Core catalytic activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:26950678
      supporting_text: >-
        the p.K212E mutation impairs the SDR5C1-dependent mitochondrial RNase P
        activities
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: EXP
  original_reference_id: PMID:9553139
  qualifier: enables
  review:
    summary: >-
      EXP 3-hydroxyacyl-CoA dehydrogenase activity from cloning/characterization of
      the purified human brain enzyme. Core catalytic activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:9553139
      supporting_text: >-
        This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of
        L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the
        D-isomers.
- term:
    id: GO:0004303
    label: estradiol 17-beta-dehydrogenase [NAD(P)+] activity
  evidence_type: EXP
  original_reference_id: PMID:10600649
  qualifier: enables
  review:
    summary: >-
      EXP 17-beta-estradiol dehydrogenase activity, kinetically characterized. Real
      but weak intrinsic steroid activity; kept as non-core.
    action: KEEP_AS_NON_CORE
    reason: Weak in-vitro steroid side activity, not the evolved core function.
    supported_by:
    - reference_id: PMID:10600649
      supporting_text: >-
        comparable with that of the enzyme's hydroxysteroid dehydrogenase (HSD)
        activity for oxidizing 17beta-oestradiol
- term:
    id: GO:0004303
    label: estradiol 17-beta-dehydrogenase [NAD(P)+] activity
  evidence_type: EXP
  original_reference_id: PMID:12917011
  qualifier: enables
  review:
    summary: >-
      EXP 17-beta-estradiol/hydroxysteroid dehydrogenase activity from the expanded
      substrate screen. Weak in-vitro steroid activity; non-core.
    action: KEEP_AS_NON_CORE
    reason: Weak in-vitro steroid side activity, not the evolved core function.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        3alpha-OH and 17beta-OH activities with sex steroids
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: EXP
  original_reference_id: PMID:12917011
  qualifier: located_in
  review:
    summary: >-
      EXP mitochondrial localization by confocal/electron microscopy; the human
      enzyme carries an N-terminal mitochondrial targeting signal. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        the human form is localized to mitochondria
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: EXP
  original_reference_id: PMID:18984158
  qualifier: located_in
  review:
    summary: EXP mitochondrial localization from the RNase P identification study. Accept.
    action: ACCEPT
- term:
    id: GO:0047015
    label: 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
  evidence_type: EXP
  original_reference_id: PMID:20077426
  qualifier: enables
  review:
    summary: >-
      EXP 2-methyl-3-hydroxybutyryl-CoA (MHBD) dehydrogenase activity, measured with
      the substrate 2-methyl-3-hydroxybutyryl-CoA on WT and disease-mutant enzymes.
      Core physiological catalytic activity (isoleucine catabolism). Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:20077426
      supporting_text: >-
        substrate 2-methyl-3-hydroxybutyryl-CoA
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: PMID:23042678
  qualifier: located_in
  review:
    summary: IDA mitochondrial localization. Accept.
    action: ACCEPT
- term:
    id: GO:0043527
    label: tRNA methyltransferase complex
  evidence_type: IPI
  original_reference_id: PMID:23042678
  qualifier: part_of
  review:
    summary: >-
      Part_of a tRNA methyltransferase complex: the MRPP1-MRPP2 (TRMT10C-SDR5C1)
      subcomplex is the m1A9/m1G9 methyltransferase, with HSD17B10 as the required
      non-catalytic partner. Accept as a valid cellular component (methyltransferase
      subcomplex of RNase P).
    action: ACCEPT
    supported_by:
    - reference_id: PMID:23042678
      supporting_text: >-
        the human mitochondrial enzyme, moreover, requires a short-chain
        dehydrogenase as a partner protein
- term:
    id: GO:0070901
    label: mitochondrial tRNA methylation
  evidence_type: IDA
  original_reference_id: PMID:23042678
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in mitochondrial tRNA methylation (m1A9/m1G9 formation by the
      MRPP1-MRPP2 subcomplex). A genuine, experimentally supported role of the RNase P
      machinery HSD17B10 is part of. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:23042678
      supporting_text: >-
        is the methyltransferase responsible for m(1)G9 and m(1)A9 formation
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: HTP
  original_reference_id: PMID:34800366
  qualifier: located_in
  review:
    summary: >-
      HTP mitochondrial localization from a high-confidence mitochondrial proteome
      study. Consistent with all evidence. Accept.
    action: ACCEPT
- term:
    id: GO:0106281
    label: chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: enables
  review:
    summary: >-
      IDA bile-acid 7-alpha-dehydrogenase activity (chenodeoxycholate/cholate) from
      the expanded substrate screen. Real in-vitro bile-acid activity; non-core.
    action: KEEP_AS_NON_CORE
    reason: In-vitro bile-acid side activity, not the evolved core function.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid
- term:
    id: GO:0106282
    label: isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: enables
  review:
    summary: >-
      IDA bile-acid 7-beta-dehydrogenase activity on (iso)ursodeoxycholic acid from
      the substrate screen. Real in-vitro bile-acid activity; non-core.
    action: KEEP_AS_NON_CORE
    reason: In-vitro bile-acid side activity, not the evolved core function.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        act as 7beta-OH dehydrogenases of ursodeoxycholic or isoursodeoxycholic acid
- term:
    id: GO:0106283
    label: ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: enables
  review:
    summary: >-
      IDA bile-acid 7-beta-dehydrogenase activity on ursodeoxycholic acid. Real
      in-vitro bile-acid activity; non-core.
    action: KEEP_AS_NON_CORE
    reason: In-vitro bile-acid side activity, not the evolved core function.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        act as 7beta-OH dehydrogenases of ursodeoxycholic or isoursodeoxycholic acid
- term:
    id: GO:0006550
    label: L-isoleucine catabolic process
  evidence_type: IDA
  original_reference_id: PMID:18996107
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in L-isoleucine catabolism from clinical/biochemical study of
      MHBD-deficient patients (deficient MHBD activity, isoleucine-pathway
      metabolites). Core biological process. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:18996107
      supporting_text: >-
        2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency
- term:
    id: GO:0006550
    label: L-isoleucine catabolic process
  evidence_type: IDA
  original_reference_id: PMID:19706438
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in isoleucine catabolism; the disease mutant fails to
      dehydrogenate 2-methyl-3-hydroxybutyryl-CoA. Core biological process. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:19706438
      supporting_text: >-
        HSD10(E249Q) was unable to catalyze the dehydrogenation of
        2-methyl-3-hydroxybutyryl-CoA
- term:
    id: GO:0044594
    label: 17-beta-hydroxysteroid dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: enables
  review:
    summary: >-
      IDA 17-beta-hydroxysteroid dehydrogenase activity from the expanded substrate
      screen. Real but weak intrinsic steroid activity; non-core.
    action: KEEP_AS_NON_CORE
    reason: Weak in-vitro steroid side activity, not the evolved core function.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        3alpha-OH and 17beta-OH activities with sex steroids
- term:
    id: GO:0047015
    label: 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:18996107
  qualifier: enables
  review:
    summary: >-
      IDA MHBD activity measured in patient fibroblasts. Core physiological catalytic
      activity (isoleucine catabolism). Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:18996107
      supporting_text: >-
        MHBD activity was clearly deficient in males
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: enables
  review:
    summary: >-
      IDA (3S)-3-hydroxyacyl-CoA dehydrogenase activity from the substrate screen.
      Core catalytic activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        In addition to the known hydroxyacyl-CoA dehydrogenase
- term:
    id: GO:0006635
    label: fatty acid beta-oxidation
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in fatty acid beta-oxidation (short/medium-chain
      3-hydroxyacyl-CoA dehydrogenase step). Accept.
    action: ACCEPT
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid
- term:
    id: GO:0006699
    label: bile acid biosynthetic process
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in bile-acid metabolism, from the in-vitro bile-acid
      dehydrogenase activities and bile-acid isomerization proposal. Real but in-vitro;
      physiological contribution unestablished. Non-core.
    action: KEEP_AS_NON_CORE
    reason: >-
      Based on in-vitro bile-acid activities; physiological role in bile-acid
      biosynthesis not established.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        participates in bile acid isomerization
- term:
    id: GO:0008207
    label: C21-steroid hormone metabolic process
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in C21-steroid (glucocorticoid/gestagen) metabolism, from the
      20-beta/21-OH oxidation activities. In-vitro steroid metabolism; non-core.
    action: KEEP_AS_NON_CORE
    reason: In-vitro steroid metabolism, not the evolved core function.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        oxidize the 20beta-OH and 21-OH groups in C21 steroids
- term:
    id: GO:0008209
    label: androgen metabolic process
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in androgen metabolism, from testosterone/androstanediol
      dehydrogenase activities. In-vitro steroid metabolism; non-core.
    action: KEEP_AS_NON_CORE
    reason: In-vitro steroid side activity, not the evolved core function.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        3alpha-OH and 17beta-OH activities with sex steroids
- term:
    id: GO:0008210
    label: estrogen metabolic process
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in estrogen metabolism, from 17-beta-estradiol dehydrogenase
      activity. In-vitro steroid metabolism; non-core.
    action: KEEP_AS_NON_CORE
    reason: In-vitro steroid side activity, not the evolved core function.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        17beta-OH activities with sex steroids
- term:
    id: GO:0008709
    label: cholate 7-alpha-dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: enables
  review:
    summary: >-
      IDA cholate 7-alpha-dehydrogenase activity from the substrate screen. Real
      in-vitro bile-acid activity; non-core.
    action: KEEP_AS_NON_CORE
    reason: In-vitro bile-acid side activity, not the evolved core function.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid
        (5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid
- term:
    id: GO:0042645
    label: mitochondrial nucleoid
  evidence_type: IDA
  original_reference_id: PMID:24703694
  qualifier: located_in
  review:
    summary: >-
      IDA localization to the mitochondrial nucleoid, where RNase P/ELAC2 initiate
      tRNA processing and ribosome assembly. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:24703694
      supporting_text: >-
        associate with nucleoids to initiate RNA processing and ribosome assembly
- term:
    id: GO:0047015
    label: 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:19706438
  qualifier: enables
  review:
    summary: >-
      IDA MHBD activity; disease mutant loses dehydrogenation of
      2-methyl-3-hydroxybutyryl-CoA. Core physiological catalytic activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:19706438
      supporting_text: >-
        HSD10(E249Q) was unable to catalyze the dehydrogenation of
        2-methyl-3-hydroxybutyryl-CoA
- term:
    id: GO:0047035
    label: testosterone dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:12917011
  qualifier: enables
  review:
    summary: >-
      IDA testosterone dehydrogenase activity from the substrate screen. In-vitro
      steroid side activity; non-core.
    action: KEEP_AS_NON_CORE
    reason: In-vitro steroid side activity, not the evolved core function.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        3alpha-OH and 17beta-OH activities with sex steroids
- term:
    id: GO:0062173
    label: brexanolone metabolic process
  evidence_type: IDA
  original_reference_id: PMID:19706438
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in brexanolone (allopregnanolone) metabolism: HSD17B10 oxidizes
      the 3-alpha-OH of this neurosteroid GABA-A modulator, and disease mutants lose
      this activity. A genuine, potentially neurologically relevant side activity;
      kept as non-core relative to the isoleucine/tRNA core roles.
    action: KEEP_AS_NON_CORE
    reason: >-
      Real neurosteroid activity of possible pathophysiological relevance, but a side
      activity rather than the evolved core function.
    supported_by:
    - reference_id: PMID:19706438
      supporting_text: >-
        the oxidation of allopregnanolone, a positive modulator of the
        gamma-aminobutyric acid type A receptor
- term:
    id: GO:0000049
    label: tRNA binding
  evidence_type: IDA
  original_reference_id: PMID:29040705
  qualifier: enables
  review:
    summary: >-
      IDA tRNA binding: the MRPP1/2 (TRMT10C/SDR5C1) complex binds and retains
      mitochondrial pre-tRNA throughout maturation. tRNA binding is the
      subunit-level molecular activity underlying HSD17B10/MRPP2's structural role in
      RNase P/tRNA processing. Accept as a core molecular function.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:29040705
      supporting_text: >-
        it retains the tRNA product from the 5'-processing step
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:25925575
  qualifier: enables
  review:
    summary: >-
      IDA 3-hydroxyacyl-CoA dehydrogenase activity assayed for disease mutants
      alongside RNase P/tRNA functions. Core catalytic activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:25925575
      supporting_text: >-
        pathogenic mutations impair SDR5C1-dependent dehydrogenation, tRNA processing
        and methylation
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:28888424
  qualifier: enables
  review:
    summary: >-
      IDA 3-hydroxyacyl-CoA dehydrogenase activity for the V12L/V176M disease mutants
      (reduced dehydrogenase activity). Core catalytic activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:28888424
      supporting_text: >-
        Both mutant proteins showed significant reduction in the dehydrogenase,
        methyltransferase and tRNA processing activities compared to wildtype
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:29040705
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding to TRMT10C (Q7L0Y3) from the MRPP1/2 tRNA-maturation
      platform study. Real and central, but bare "protein binding" is uninformative;
      functional meaning captured by the RNase P complex/process annotations.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Uninformative generic protein-binding term; TRMT10C interaction captured by
      complex/process annotations.
- term:
    id: GO:0030678
    label: mitochondrial ribonuclease P complex
  evidence_type: IDA
  original_reference_id: PMID:25925575
  qualifier: part_of
  review:
    summary: >-
      IDA part_of the mitochondrial RNase P complex; disease mutations disrupt
      complex assembly/interaction with TRMT10C. Core cellular component. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:25925575
      supporting_text: >-
        moonlighting as a component of human mitochondrial RNase P
- term:
    id: GO:0030678
    label: mitochondrial ribonuclease P complex
  evidence_type: IDA
  original_reference_id: PMID:28888424
  qualifier: part_of
  review:
    summary: >-
      IDA part_of the mitochondrial RNase P complex (MRPP1/MRPP2/MRPP3). Core
      cellular component. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:28888424
      supporting_text: >-
        in a complex with MRPP1 and MRPP3 (also known as PRORP) proteins for 5'-end
        processing of mitochondrial precursor tRNA
- term:
    id: GO:0051289
    label: protein homotetramerization
  evidence_type: IDA
  original_reference_id: PMID:25925575
  qualifier: involved_in
  review:
    summary: >-
      IDA protein homotetramerization; HSD17B10 functions as a homotetramer and some
      disease mutations disrupt tetramerization. A genuine, structurally important
      property. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:25925575
      supporting_text: >-
        Some mutations disrupt the homotetramerization of SDR5C1
- term:
    id: GO:0070901
    label: mitochondrial tRNA methylation
  evidence_type: IDA
  original_reference_id: PMID:25925575
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in mitochondrial tRNA methylation (m1A9/m1G9); disease mutations
      impair methylation. Genuine RNase P subcomplex role. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:25925575
      supporting_text: >-
        pathogenic mutations impair SDR5C1-dependent dehydrogenation, tRNA processing
        and methylation
- term:
    id: GO:0070901
    label: mitochondrial tRNA methylation
  evidence_type: IDA
  original_reference_id: PMID:28888424
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in mitochondrial tRNA methylation; V12L/V176M mutants show
      reduced methyltransferase activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:28888424
      supporting_text: >-
        N1-methylation of purines at position 9 of mitochondrial tRNA
- term:
    id: GO:0097745
    label: mitochondrial tRNA 5'-end processing
  evidence_type: IDA
  original_reference_id: PMID:24549042
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in mitochondrial tRNA 5'-end processing; knock-down / patient
      mutation impairs heavy-strand transcript processing. Core biological process.
      Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:24549042
      supporting_text: >-
        evidence of impaired processing of precursor tRNA transcripts of the
        mitochondrial heavy strand
- term:
    id: GO:0097745
    label: mitochondrial tRNA 5'-end processing
  evidence_type: IDA
  original_reference_id: PMID:25925575
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in mitochondrial tRNA 5'-end processing; disease mutations
      impair RNase P tRNA processing. Core biological process. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:25925575
      supporting_text: >-
        the enzyme removing 5'-extensions of tRNAs, an early and crucial step in tRNA
        maturation
- term:
    id: GO:0097745
    label: mitochondrial tRNA 5'-end processing
  evidence_type: IDA
  original_reference_id: PMID:28888424
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in mitochondrial tRNA 5'-end processing; disease mutants show
      reduced tRNA processing. Core biological process. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:28888424
      supporting_text: >-
        5'-end processing of mitochondrial precursor tRNA
- term:
    id: GO:0097745
    label: mitochondrial tRNA 5'-end processing
  evidence_type: IDA
  original_reference_id: PMID:29040705
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in mitochondrial tRNA 5'-end processing; MRPP1/2 mediates
      RNase P 5'-leader removal. Core biological process. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:29040705
      supporting_text: >-
        MRPP1/2 is not only responsible for mitochondrial RNase P-based 5'-leader
        removal
- term:
    id: GO:1990180
    label: mitochondrial tRNA 3'-end processing
  evidence_type: IDA
  original_reference_id: PMID:29040705
  qualifier: involved_in
  review:
    summary: >-
      IDA involvement in mitochondrial tRNA 3'-end processing: the MRPP1/2 platform
      retains the tRNA after 5'-cleavage and enhances ELAC2-catalyzed 3'-processing.
      Real platform-associated role; kept as non-core relative to the 5'-processing
      core (HSD17B10 does not itself perform 3'-cleavage).
    action: KEEP_AS_NON_CORE
    reason: >-
      Platform-supported 3'-processing role; ancillary to the core RNase P
      5'-processing function.
    supported_by:
    - reference_id: PMID:29040705
      supporting_text: >-
        significantly enhances the efficiency of ELAC2-catalyzed 3'-processing for 17
        of the 22 tRNAs
- term:
    id: GO:0007005
    label: mitochondrion organization
  evidence_type: IMP
  original_reference_id: PMID:20077426
  qualifier: involved_in
  review:
    summary: >-
      IMP involvement in mitochondrion organization: knock-down/knock-out and disease
      mutations disrupt mitochondrial structural integrity (cristae) independently of
      dehydrogenase activity. This reflects the essential non-enzymatic (RNase
      P/tRNA-processing) role. A genuine but downstream/pleiotropic process; kept as
      non-core.
    action: KEEP_AS_NON_CORE
    reason: >-
      Genuine IMP phenotype but a downstream consequence of the RNase P/tRNA-processing
      role; more specific molecular roles capture the core function.
    supported_by:
    - reference_id: PMID:20077426
      supporting_text: >-
        a property of HSD10 independent of its enzymatic activity is essential for
        structural and functional integrity of mitochondria
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:23042678
  qualifier: enables
  review:
    summary: >-
      IDA 3-hydroxyacyl-CoA dehydrogenase activity (CAFA-assigned) associated with the
      methyltransferase-subcomplex study. Core catalytic activity. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:23042678
      supporting_text: >-
        a fatty and amino acid degradation enzyme in tRNA methylation
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:23042678
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding to TRMT10C (Q7L0Y3), the methyltransferase partner. Real and
      central, but bare "protein binding" is uninformative; captured by the RNase P /
      methyltransferase complex annotations.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Uninformative generic protein-binding term; TRMT10C interaction captured by
      complex annotations.
- term:
    id: GO:0030678
    label: mitochondrial ribonuclease P complex
  evidence_type: TAS
  original_reference_id: PMID:23042678
  qualifier: part_of
  review:
    summary: >-
      TAS part_of the mitochondrial RNase P complex. Core cellular component,
      independently supported by IDA. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: PMID:23042678
      supporting_text: >-
        a subcomplex of human mitochondrial RNase P
- term:
    id: GO:0003723
    label: RNA binding
  evidence_type: HDA
  original_reference_id: PMID:22681889
  qualifier: enables
  review:
    summary: >-
      HDA RNA binding from a global mRNA-interactome capture screen. HSD17B10 does
      bind tRNA (specifically captured by GO:0000049), but this high-throughput
      generic "RNA binding" from a poly(A)-mRNA capture experiment is a non-specific
      over-annotation for a protein whose relevant RNA ligand is tRNA.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Non-specific high-throughput RNA-binding capture; the specific and relevant
      activity (tRNA binding) is separately and better annotated.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-508369
  qualifier: located_in
  review:
    summary: >-
      TAS (Reactome) mitochondrial-matrix localization for the isoleucine-catabolism
      reaction. Consistent with the authoritative matrix localization. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        Mitochondrion matrix
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6787591
  qualifier: located_in
  review:
    summary: >-
      TAS (Reactome) mitochondrial-matrix localization for the tRNA m1G9 methylation
      reaction. Consistent with authoritative matrix localization. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        Mitochondrion matrix
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6787594
  qualifier: located_in
  review:
    summary: >-
      TAS (Reactome) mitochondrial-matrix localization for the tRNA m1A9 methylation
      reaction. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        Mitochondrion matrix
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-70837
  qualifier: located_in
  review:
    summary: >-
      TAS (Reactome) mitochondrial-matrix localization for the isoleucine-catabolism
      (MHBD) reaction. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        Mitochondrion matrix
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9838081
  qualifier: located_in
  review:
    summary: >-
      TAS (Reactome) mitochondrial-matrix localization (LONP1 matrix-protein
      degradation context). Localization consistent with authoritative matrix
      localization. Accept.
    action: ACCEPT
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        Mitochondrion matrix
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9838093
  qualifier: located_in
  review:
    summary: >-
      TAS (Reactome) mitochondrial-matrix localization (LONP1 matrix-protein binding
      context). Accept.
    action: ACCEPT
    supported_by:
    - reference_id: file:human/HSD17B10/HSD17B10-uniprot.txt
      supporting_text: >-
        Mitochondrion matrix
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: located_in
  review:
    summary: >-
      ISS mitochondrial localization by orthology to mouse (O08756). Consistent with
      all experimental data. Accept.
    action: ACCEPT
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: TAS
  original_reference_id: PMID:9338779
  qualifier: located_in
  review:
    summary: >-
      TAS cytoplasm from the 1997 ERAB discovery paper, which reported an
      ER/plasma-membrane-associated Aβ-binding protein. This localization is a legacy
      mis-assignment superseded by all subsequent work establishing the protein as
      mitochondrial (matrix/nucleoid). Over-annotated.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Legacy mislocalization from the original ERAB paper; superseded by mitochondrial
      matrix/nucleoid localization in all later studies.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        the human form is localized to mitochondria
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: PMID:9338779
  qualifier: located_in
  review:
    summary: >-
      TAS plasma membrane from the 1997 ERAB discovery paper. A legacy
      mis-assignment; the protein is a mitochondrial-matrix enzyme with no established
      plasma-membrane role. Over-annotated.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Legacy mislocalization from the original ERAB paper; superseded by mitochondrial
      localization.
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        the human form is localized to mitochondria
- term:
    id: GO:0006629
    label: lipid metabolic process
  evidence_type: TAS
  original_reference_id: PMID:9338779
  qualifier: involved_in
  review:
    summary: >-
      TAS broad "lipid metabolic process" from the 1997 ERAB paper. HSD17B10 does have
      fatty-acid/cardiolipin/steroid-lipid activities, so a lipid-metabolism parent is
      not wrong, but this is a very general term captured better by fatty acid
      beta-oxidation. Kept as non-core.
    action: KEEP_AS_NON_CORE
    reason: Over-general parent; more specific lipid processes are separately annotated.
- term:
    id: GO:0008709
    label: cholate 7-alpha-dehydrogenase (NAD+) activity
  evidence_type: TAS
  original_reference_id: PMID:9338779
  qualifier: enables
  review:
    summary: >-
      TAS cholate 7-alpha-dehydrogenase activity attributed to the 1997 ERAB paper,
      which did NOT establish bile-acid activity (it described an Aβ-binding
      dehydrogenase); the bile-acid activity was actually characterized later
      (PMID:12917011, separately annotated by IDA). The activity itself is a real but
      non-core in-vitro side activity, so this is kept as non-core; note that the 1997
      citation is a legacy mis-attribution and the true support is PMID:12917011.
    action: KEEP_AS_NON_CORE
    reason: >-
      Real but non-core in-vitro bile-acid side activity; the cited 1997 paper does not
      actually support it (true support is the later IDA, PMID:12917011).
    supported_by:
    - reference_id: PMID:12917011
      supporting_text: >-
        the human orthologue oxidizes the 7alpha-OH of chenodeoxycholic acid
        (5beta-cholanic acid, 3alpha,7alpha-diol) and cholic acid
core_functions:
- description: >-
    NAD+-dependent (S)-2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) acting in
    the mitochondrial matrix in L-isoleucine catabolism, oxidizing
    (2S,3S)-3-hydroxy-2-methylbutanoyl-CoA to 2-methyl-3-oxobutanoyl-CoA; the enzyme
    also has broad short/medium-chain (S)-3-hydroxyacyl-CoA dehydrogenase activity in
    fatty acid beta-oxidation. Deficiency of this activity causes the MHBD organic
    aciduria.
  molecular_function:
    id: GO:0047015
    label: 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
  directly_involved_in:
  - id: GO:0006550
    label: L-isoleucine catabolic process
  - id: GO:0006635
    label: fatty acid beta-oxidation
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  supported_by:
  - reference_id: PMID:19706438
    supporting_text: >-
      HSD10(E249Q) was unable to catalyze the dehydrogenation of
      2-methyl-3-hydroxybutyryl-CoA
  - reference_id: PMID:20077426
    supporting_text: >-
      the mitochondrial enzyme 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD)
      involved in isoleucine metabolism
  - reference_id: PMID:9553139
    supporting_text: >-
      This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of
      L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the
      D-isomers.
- description: >-
    Broad-substrate NAD+-dependent (S)-3-hydroxyacyl-CoA dehydrogenase catalyzing the
    third step of mitochondrial fatty acid beta-oxidation, with NAD+ as the required
    cofactor bound in a Rossmann fold. This is the family-defining SDR catalytic
    activity underlying the MHBD and other hydroxyacyl-CoA/hydroxysteroid activities.
  molecular_function:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  directly_involved_in:
  - id: GO:0006635
    label: fatty acid beta-oxidation
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  supported_by:
  - reference_id: PMID:9553139
    supporting_text: >-
      This NAD+-dependent dehydrogenase catalyzes the reversible oxidation of
      L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the
      D-isomers.
  - reference_id: PMID:12917011
    supporting_text: >-
      In addition to the known hydroxyacyl-CoA dehydrogenase
- description: >-
    Essential non-catalytic (moonlighting) structural subunit MRPP2 of mitochondrial
    RNase P. As a homotetramer it binds mitochondrial pre-tRNA and, together with the
    methyltransferase TRMT10C/MRPP1 and the nuclease PRORP/MRPP3, carries out 5'-end
    processing of mitochondrial tRNAs; the TRMT10C-HSD17B10 subcomplex also acts as a
    tRNA-maturation platform and enables N1-methylation of purine-9 (m1A9/m1G9). This
    role is independent of the enzyme's dehydrogenase activity, and its loss underlies
    the severity of HSD10 mitochondrial disease.
  molecular_function:
    id: GO:0000049
    label: tRNA binding
  directly_involved_in:
  - id: GO:0097745
    label: mitochondrial tRNA 5'-end processing
  - id: GO:0070901
    label: mitochondrial tRNA methylation
  in_complex:
    id: GO:0030678
    label: mitochondrial ribonuclease P complex
  supported_by:
  - reference_id: PMID:18984158
    supporting_text: >-
      human mitochondrial RNase P is a protein enzyme that does not require a
      trans-acting RNA component for catalysis
  - reference_id: PMID:29040705
    supporting_text: >-
      it retains the tRNA product from the 5'-processing step
  - reference_id: PMID:23042678
    supporting_text: >-
      the human mitochondrial enzyme, moreover, requires a short-chain dehydrogenase
      as a partner protein
  - reference_id: PMID:20077426
    supporting_text: >-
      a property of HSD10 independent of its enzymatic activity is essential for
      structural and functional integrity of mitochondria
proposed_new_terms: []
suggested_questions:
- question: >-
    Which of HSD17B10's catalytic activities (isoleucine-pathway MHBD, general
    3-hydroxyacyl-CoA, neurosteroid/allopregnanolone, cardiolipin phospholipase) are
    physiologically significant in vivo versus in-vitro artifacts of a broad-specificity
    SDR active site?
- question: >-
    How does the non-catalytic RNase P/tRNA-processing role mechanistically account for
    HSD10 disease severity, and can it be uncoupled therapeutically from the metabolic
    (isoleucine) role?
- question: >-
    Does the neurosteroid (allopregnanolone/brexanolone) oxidation activity contribute
    to the neurological phenotype of HSD10 disease independently of tRNA processing?
suggested_experiments:
- description: >-
    Separation-of-function mutants that selectively abolish either dehydrogenase
    activity or RNase P/TRMT10C-binding, tested in patient-derived and knockout cells
    for mitochondrial tRNA processing, respiratory chain assembly, and viability.
- description: >-
    Quantitative in-vivo metabolic flux analysis of isoleucine catabolism and
    neurosteroid (allopregnanolone) levels in HSD10-deficient models to define which
    metabolic defects contribute to neuropathology.
- description: >-
    Structural and biochemical dissection of how the HSD17B10 homotetramer scaffolds
    TRMT10C and pre-tRNA across the sequential 5'-processing, methylation, 3'-processing
    and CCA-addition steps.
references:
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000041
  title: Gene Ontology annotation based on UniPathway vocabulary mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000116
  title: Automatic Gene Ontology annotation based on Rhea mapping
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:9338779
  title: An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity
    in Alzheimer's disease.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      The original ERAB/Aβ discovery paper. Establishes the Aβ (APP) interaction, but
      its cytoplasm/plasma-membrane/ER localization and bile-acid TAS assignments are
      legacy mis-assignments superseded by later mitochondrial-matrix work.
- id: PMID:9553139
  title: A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an
    amyloid beta-peptide-binding protein involved in Alzheimer's disease.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Cloning and biochemical characterization establishing the core NAD+-dependent
      (3S)-3-hydroxyacyl-CoA dehydrogenase activity; identical to ERAB.
- id: PMID:10600649
  title: Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities
    of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Kinetic characterization showing the alcohol/hydroxysteroid activities are orders
      of magnitude weaker than the 3-hydroxyacyl-CoA activity, supporting non-core status
      of the steroid/ADH side activities.
- id: PMID:12917011
  title: 'Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid
    dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone
    metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD.'
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Definitive substrate screen and mitochondrial localization; source of most steroid
      and bile-acid MF/BP annotations (in-vitro, non-core).
- id: PMID:18984158
  title: 'RNase P without RNA: identification and functional reconstitution of the
    human mitochondrial tRNA processing enzyme.'
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Identified HSD17B10/MRPP2 as an essential subunit of the protein-only mitochondrial
      RNase P; foundational for the tRNA-processing core function.
- id: PMID:18996107
  title: 'Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase
    (MHBD) deficiency: difficulties in the diagnosis.'
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Patient/carrier study of MHBD deficiency supporting the isoleucine-catabolism role.
- id: PMID:19706438
  title: Mental retardation linked to mutations in the HSD17B10 gene interfering with
    neurosteroid and isoleucine metabolism.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Links disease mutations to loss of both MHBD (isoleucine) and allopregnanolone
      (neurosteroid) oxidation; source of the brexanolone metabolic process annotation.
- id: PMID:20077426
  title: A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is
    required for mitochondrial integrity and cell survival.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Key evidence that disease severity is independent of enzymatic activity and driven
      by an essential non-enzymatic mitochondrial-integrity function; also the 1.2 A
      crystal structure.
- id: PMID:21593607
  title: Involvement of human ELAC2 gene product in 3' end processing of mitochondrial
    tRNAs.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      ELAC2 mitochondrial 3'-processing study; source of a NAS mitochondrion
      localization for HSD17B10 in the context of the tRNA-processing machinery.
- id: PMID:22681889
  title: The mRNA-bound proteome and its global occupancy profile on protein-coding
    transcripts.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Global mRNA-interactome capture screen; source of the non-specific HDA "RNA
      binding" annotation, marked over-annotated (the relevant ligand is tRNA).
- id: PMID:23042678
  title: A subcomplex of human mitochondrial RNase P is a bifunctional methyltransferase--extensive
    moonlighting in mitochondrial tRNA biogenesis.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Establishes the MRPP1-MRPP2 subcomplex as the m1A9/m1G9 methyltransferase requiring
      HSD17B10 as a non-catalytic partner.
- id: PMID:24549042
  title: Mutation or knock-down of 17β-hydroxysteroid dehydrogenase type 10 cause
    loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Shows HSD17B10 maintains MRPP1 levels and that its loss impairs heavy-strand
      mitochondrial tRNA processing; disease-relevant.
- id: PMID:24703694
  title: Initial steps in RNA processing and ribosome assembly occur at mitochondrial
    DNA nucleoids.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Localizes RNase P/ELAC2 to mtDNA nucleoids; supports the mitochondrial-nucleoid
      localization annotation.
- id: PMID:25575635
  title: Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript
    processing.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Supports that HSD10 disease pathology stems from defective mtDNA transcript (tRNA)
      processing rather than the metabolic defect. Cited in notes; not an existing GOA
      annotation source.
- id: PMID:25925575
  title: 'Molecular insights into HSD10 disease: impact of SDR5C1 mutations on the
    human mitochondrial RNase P complex.'
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Shows disease mutations impair dehydrogenation, tRNA processing, methylation,
      homotetramerization and TRMT10C interaction; source of several core annotations.
- id: PMID:26338420
  title: Myxococcus CsgA, Drosophila Sniffer, and human HSD10 are cardiolipin phospholipases.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Establishes the cardiolipin phospholipase C-like (cardiolipin dehydrogenase)
      activity, inhibited by Aβ; a distinct in-vitro moonlighting activity (non-core).
- id: PMID:26950678
  title: A novel HSD17B10 mutation impairing the activities of the mitochondrial RNase
    P complex causes X-linked intractable epilepsy and neurodevelopmental regression.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      K212E patient mutation impairing SDR5C1-dependent RNase P activities; source of an
      EXP dehydrogenase annotation.
- id: PMID:28514442
  title: Architecture of the human interactome defines protein communities and disease
    networks.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput interactome study; source of a bare protein-binding (TRMT10C) IPI,
      marked over-annotated.
- id: PMID:28888424
  title: Novel patient missense mutations in the HSD17B10 gene affect dehydrogenase
    and mitochondrial tRNA modification functions of the encoded protein.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      V12L/V176M patient mutations reduce dehydrogenase, methyltransferase and tRNA
      processing; clean statement of the dual catalytic/non-catalytic functions.
- id: PMID:29040705
  title: The MRPP1/MRPP2 complex is a tRNA-maturation platform in human mitochondria.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Shows MRPP1/2 retains tRNA after 5'-cleavage, enhances ELAC2 3'-processing and
      presents tRNA to the CCA-adding enzyme; source of tRNA-binding and processing
      annotations.
- id: PMID:29128334
  title: A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration
    Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Mitochondrial interactome map; source of bare protein-binding IPIs (EEF2, TRAP1)
      of unclear functional significance, marked over-annotated.
- id: PMID:29880640
  title: Structural insight into the human mitochondrial tRNA purine N1-methyltransferase
    and ribonuclease P complexes.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Structural study of the MRPP1/MRPP2 and RNase P complexes; source of RNase P
      complex, mitochondrion and 5'-processing annotations.
- id: PMID:32814053
  title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
    and Uncovers Widespread Protein Aggregation in Affected Brains.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Neurodegeneration interactome; source of a bare protein-binding (APP/Aβ) IPI,
      marked over-annotated.
- id: PMID:32825572
  title: 'Study of Biomolecular Interactions of Mitochondrial Proteins Related to
    Alzheimer''s Disease: Toward Multi-Interaction Biomolecular Processes.'
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Alzheimer-related mitochondrial interaction study; source of a bare protein-binding
      (Aβ peptide) IPI, marked over-annotated.
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Proteome-scale interactome; source of a bare protein-binding (TRMT10C) IPI, marked
      over-annotated.
- id: PMID:34800366
  title: Quantitative high-confidence human mitochondrial proteome and its dynamics
    in cellular context.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: High-confidence mitochondrial proteome; supports mitochondrion localization.
- id: PMID:38824131
  title: Structural basis for human mitochondrial tRNA maturation.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Cryo-EM of the four mt-tRNA maturation steps; supports the maturation-platform,
      CCA-addition and catalytic-complex annotations.
- id: PMID:39516281
  title: Structural basis of 3'-tRNA maturation by the human mitochondrial RNase Z
    complex.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Cryo-EM of the mitochondrial RNase Z (ELAC2/SDR5C1/TRMT10C) complex; supports the
      3'-processing and endoribonuclease-complex annotations.
- id: Reactome:R-HSA-508369
  title: alpha-methylacetoacetyl-CoA + NADH + H+ <=> alpha-methyl-beta-hydroxybutyryl-CoA
    + NAD+
  findings: []
- id: Reactome:R-HSA-6787591
  title: TRMT10C:HSD17B10 (TRMT10C:SDR5C1) of mitochondrial RNase P methylates guanosine-9
    in tRNA yielding 1-methylguanosine-9
  findings: []
- id: Reactome:R-HSA-6787594
  title: TRMT10C:HSD17B10 (TRMT10C:SDR5C1) methylates adenosine-9 in tRNA yielding
    1-methyladenosine-9
  findings: []
- id: Reactome:R-HSA-70837
  title: alpha-methyl-beta-hydroxybutyryl-CoA + NAD+ <=> alpha-methylacetoacetyl-CoA
    + NADH + H+
  findings: []
- id: Reactome:R-HSA-9838081
  title: LONP1 degrades mitochondrial matrix proteins
  findings: []
- id: Reactome:R-HSA-9838093
  title: LONP1 binds mitochondrial matrix proteins
  findings: []